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Transcriptional profiling of liver during the
critical embryo-to-hatchling transition
period in the chicken (Gallus gallus)
Larry A. Cogburn1* , Nares Trakooljul1,4, Chuming Chen2, Hongzhan Huang2, Cathy H. Wu2, Wilfrid Carré1,5,
Xiaofei Wang1,6 and Harold B. White III3

Abstract
Background: Although hatching is perhaps the most abrupt and profound metabolic challenge that a chicken
must undergo; there have been no attempts to functionally map the metabolic pathways induced in liver during
the embryo-to-hatchling transition. Furthermore, we know very little about the metabolic and regulatory factors
that regulate lipid metabolism in late embryos or newly-hatched chicks. In the present study, we examined hepatic
transcriptomes of 12 embryos and 12 hatchling chicks during the peri-hatch period—or the metabolic switch from
chorioallantoic to pulmonary respiration.
Results: Initial hierarchical clustering revealed two distinct, albeit opposing, patterns of hepatic gene expression.
Cluster A genes are largely lipolytic and highly expressed in embryos. While, Cluster B genes are lipogenic/thermogenic
and mainly controlled by the lipogenic transcription factor THRSPA. Using pairwise comparisons of embryo and hatchling
ages, we found 1272 genes that were differentially expressed between embryos and hatchling chicks, including 24
transcription factors and 284 genes that regulate lipid metabolism. The three most differentially-expressed transcripts
found in liver of embryos were MOGAT1, DIO3 and PDK4, whereas THRSPA, FASN and DIO2 were highest in hatchlings.
An unusual finding was the “ectopic” and extremely high differentially expression of seven feather keratin transcripts in
liver of 16 day embryos, which coincides with engorgement of liver with yolk lipids. Gene interaction networks show
several transcription factors, transcriptional co-activators/co-inhibitors and their downstream genes that exert a
‘ying-yang’ action on lipid metabolism during the embryo-to-hatching transition. These upstream regulators
include ligand-activated transcription factors, sirtuins and Kruppel-like factors.
Conclusions: Our genome-wide transcriptional analysis has greatly expanded the hepatic repertoire of regulatory and
metabolic genes involved in the embryo-to-hatchling transition. New knowledge was gained on interactive
transcriptional networks and metabolic pathways that enable the abrupt switch from ectothermy (embryo) to
endothermy (hatchling) in the chicken. Several transcription factors and their coactivators/co-inhibitors appear
to exert opposing actions on lipid metabolism, leading to the predominance of lipolysis in embryos and lipogenesis in
hatchlings. Our analysis of hepatic transcriptomes has enabled discovery of opposing, interconnected and interdependent
transcriptional regulators that provide precise ying-yang or homeorhetic regulation of lipid metabolism during the critical
embryo-to-hatchling transition.
Keywords: Metabolic switch, Lipolysis, Lipogenesis, Opposing up-stream regulators, THRSPA, SERTAD2, Kruppel-like
factors, Hepatic FKER, Coagulation system, Homeorhetric regulation of metabolism, Transcriptional activation/inactivation
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Background
The developing mammalian embryo is completely
dependent upon its mother and her placenta to supply
nutrients, exchange respiratory gases, and to remove nitrogenous waste products. Quite the opposite is true
among amniotes (i.e., birds and reptiles), which must
undergo independent embryonic development in a
pre-formed and completely enclosed system—the cleidoic egg. In chickens, the principal source of energy for
late embryonic growth is derived from yolk lipids stored
in the egg by the hen. The embryo exhibits exponential
growth between days 13 to 18 of embryonic development (E13 to E18), when the total energy required for
growth comes from β-oxidation of fatty acids derived
from yolk lipids [1, 2]. The final phase of embryonic development is marked by a dramatic accumulation of
cholesterol esters in the liver (> 30% of its dry mass) [3].
Just prior to hatching, the yolk sac and its remaining
lipids are retracted into the embryo’s visceral cavity to
fuel the ensuing metabolic switch to endothermy in
hatchling chicks. Yolk lipids are utilized by the newly
hatched chicken from direct transfer into circulation via
transport from the yolk stalk into the small intestine [4].
Although fatty acids are readily absorbed from the lipid
drenched intestine, the absorption of carbohydrates and
amino acids from ingested high-energy feed is delayed
until expression of intestinal enzymes and cotransporters
(glucose/sodium/amino acid) reach adequate levels [4–7].
A recent transcriptional analysis, using serial analysis of
gene expression (SAGE), of the chick embryo yolk sac
between E13 and E21 [8] provides the first view of
genome-wide transcriptional changes that occur during
transport of lipid from the yolk sac into the liver prior to
hatching. The high abundance of yolk lipids and their
transporters (i.e., lipoproteins) appear to interfere with absorption and utilization of nutrients from the intestine of
the immediate post-hatch chick [4–6]. Thus, the newly
hatched chick must undergo a dramatic metabolic shift
from ectothermy, with an exclusive dependence on yolk
lipids, to endothermy which depends on utilization of
ingested feed—mainly carbohydrates and protein [5]. Early
hepatic expression of several lipogenic enzymes [9–11]
provides the chick with the ability to convert dietary
carbohydrate into fat stores [2]. This sudden switch from
a dependence on fat stored in yolk (embryos) to utilization
of nutrients in feed (hatchling) requires major shifts in nutrient transport and metabolism that are controlled by yet
uncharted genetic pathways. Although newly hatched
chicks can survive for several days on residual yolk, delayed feeding prevents full recovery and normal growth,
despite a brief compensatory growth spurt [12]. Prolonged
starvation during the immediate post-hatch period retards
body and muscle growth, which is irreversible due to cellular changes in skeletal muscle [13]. Although hatching is
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perhaps the most abrupt and profound metabolic challenge that a chicken must experience, there have been no
attempts to functionally map the metabolic pathways induced by nutrients in the chick’s first meal. Furthermore,
we know very little about transcriptional control of multiple metabolic and regulatory factors that control metabolism during the critical immediate post-hatch period.
The chicken embryo develops as an aquatic ectotherm
with respiratory gas exchange via the chorioallantoic
membrane. On the last day of embryonation (E21), the
fully-developed embryo must suddenly convert to pulmonary respiration after pipping through the eggshell.
During the peri-hatch period, the precocious chick becomes an endotherm with a very high and self-sustaining
metabolic rate maintained by a fully-functional thermoregulatory system. The thyroid axis plays a major role in
regulating metabolism and energy expenditure. Hence, the
activity and importance of the thyroid axis has been extensively studied during the peri-hatch period of the chicken
[14–18]. The thyroid axis prepares the embryo for this
metabolic jump with decreased activity of the inactivating
deiodinase (DIO3) at E20, whereas the activity of the activating deiodinases (DIO1 and DIO2) increases in E20 embryos during hatching and afterwards in the hatchling.
The pro-thyroid hormone (T4) is readily deactivated to reverse rT3 by DIO3 in liver of E16 and E18 embryos; then
with onset of pulmonary respiration, the activity of
(DIO1) and (DIO2) increases in liver to meet the ensuing
energy demands of hatching and endothermy. The embryo must switch from chorio-allantoic to pulmonary respiration and instantly meet the high metabolic demands
of an endotherm—the hatchling chick. Therefore, it is essential to understand the transcriptional networks that integrate and control function of the endocrine system to
meet the dynamic metabolic demands of growth imposed
upon the liver.
Our first glimpse of the liver transcriptome during the
chicken’s peri-hatch period came from an earlier lowresolution transcriptional scan using the original chicken
liver (3.2 K) microarray [19]. This initial transcriptional
study using our prototype microarray was completed
with 24 liver samples taken during the peri-hatch period
[embryonic day 16 (E16) to post-hatch day 9 (D9)]. Self-organizing maps (SOMs) clustering of the 3.2 K microarray
data identified two distinct gene expression profiles in liver.
Cluster A contained differentially-expressed genes (DEGs)
with very high expression in hatching liver, while Cluster B
DEGs showed higher expression in embryo liver (see Fig. 2
in [19]). Hepatic expression of several lipolytic genes was
higher in embryos and then abruptly decreased after
hatching. In contrast, many up-regulated genes in liver
of hatchling chicks control lipogenesis and energy metabolism (THRSPΑ, SCD, FASN, ME1, HMGCS, and
EVOL6).
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The present high-resolution genome-wide transcriptional analysis of the liver during the peri-hatch period
has greatly expanded our hepatic repertoire of regulatory and metabolic genes involved in the embryoto-hatchling transition. Several transcription factors
were identified that appear to exert opposing actions,
which lead to the predominance of lipolysis in embryos or lipogenesis in hatchlings. Furthermore, we
have gained new knowledge on interactive transcriptional networks and metabolic pathways that enable the
abrupt switch from ectothermy (embryo) to endothermy
(hatchling) in the chicken.

Methods
Animal care and use

Fertile eggs from Ross x Ross broiler (meat-type) chickens
were purchased from a commercial hatchery (Moyer’s,
Quakertown, PA). The eggs were incubated in an automated incubator (Jamesway Incubator Co., Ontario CAN)
at 39 °C and 95% relative humidity. At E20, eggs containing viable embryos were transferred to hatching trays to
determine the approximate time of hatch (i.e., wetness of
down). Chicks hatched within a 4 h period on the 21st day
of incubation were wing-banded and held in the incubator
for an additional 4 h. The remaining one day-old (D1)
chicks were vaccinated against Marek’s disease virus
and transferred to a heated battery brooder (Petersime
Incubator Co., Gettysburg OH) maintained at 33 °C.
The chicks received a commercial starter ration (22%
crude protein and 3100 kcal ME/kg) and water ad libitum throughout the experiment. After continuous
light for the first two days, the birds were maintained
on a 20 h light: 4 h dark (20 L:4D) photoperiod. All
protocols used in this study were in accordance with
the United States Department of Agriculture guidelines on the use of agricultural animals in research
and approved by the University of Delaware Animal
Care and Use Committee.
Experimental design of hepatic transcriptional profiling
study

The experimental design used for the present transcriptional profiling with Affymetrix Chicken Genome
arrays was similar to the design utilized in our original
3.2 K microarray analysis of liver in peri-hatch chickens [19]. Four male embryos were killed for collection
of liver samples on embryonic day 16 (E16), E18 and
E20 and four male hatchlings taken at 1, 3 and 9 day
(D) of age. The D1 liver samples were taken from
hatched chicks held in the hatching incubator (38 °C)
for 4 h. After visual verification of male sex (presence
of testes), each liver was quickly removed, placed into
a 15 ml Nalgene cryogenic vial and snap frozen in liquid nitrogen. The remaining chicks were provide
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with feed and water ad libitum and housed in a heated
battery brooder maintained at under a 20 L:4D photoperiod. The frozen liver samples were transferred to
an ultra-low freezer (− 85 °C) and stored until isolation of total RNA.
Extraction and purification of total RNA

Total RNA was purified from each liver sample using an
RNeasy Mini kit with on column DNase I treatment, as
recommended by the manufacturer’s (Qiagen, Valencia,
CA). Quantitation of total RNA was done using a
NanoDrop spectrophotometer (NanoDrop, Wilmington DE) and the RNA was diluted to a standard concentration (250 ng/μL). RNA quality was assessed using
an Agilent 2100 Bioanalyzer and an Agilent RNA 6000
Nano Kit (Agilent Genomics, Santa Clara, CA). Liver RNA
samples (1 μL each) were analyzed on a RNA 6000 Nano
Chip. The ribosomal RNA ratio (28S/18S) was assessed for
RNA integrity, where with a RNA Integrity Number
(RIN) of 9 to 10 indicates RNA of high quality for use
in amplification of RNA for the microarray analysis
and for verification by qRT-PCR analysis. Each liver
RNA sample was divided into two identical aliquots
and stored frozen at − 85 °C until use in the transcriptional analyses below.
RNA amplification, biotin labeling and hybridization of
chicken genome arrays

Microarray-based transcriptome profiling was carried
out using 24 Affymetrix GeneChip™ Chicken Genome
Arrays and one-cycle target labeling protocol according
to the manufacturer’s (Affymetrix) protocols. The experimental design for hybridization of the 24 chicken
genome arrays was based on four replicate hybridization
days, where all six ages were represented by one of four
biological replicates (individual embryo or hatchling) per
age group (Additional file 1). Briefly, 5 μg of total
RNA was reverse-transcribed into first-strand cDNA
using a T7-oligo(dT) promoter primers, followed by
RNase H-mediated second-strand cDNA synthesis.
and subsequently in vitro transcribed (IVT) into biotinylated complementary RNA (cRNA) in the present of
T7 RNA Polymerase and biotinylated nucleotide analog/
ribonucleotide mix using the Affymetrix IVT Labeling Kit
(Affymetrix, Santa Clara, CA). The biotin-labeled cRNAs
were cleaned up, fragmented and quality checked on an
Agilent 2100 Bioanalyzer and hybridized to Chicken
GeneChip™ Arrays for 16 h. The probe arrays were washed
and stained on the Affymetrix GeneChip™ Fluidics Station
and scanned for raw intensity data on the Agilent GeneChip™ Scanner using GeneChip™ Operating Software
(GCOS) on the Affymetrix GeneChip™ Workstation. The
raw cel files were then used for pre-processing and
normalization as describe below.
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Processing, normalization and statistical analysis of
genome array data

An initial visual analysis (including hierarchical and
K-mean clustering) of the microarray data was completed using GeneSpring GX software (Agilent, Santa
Clara, CA). Raw cell files from the Affymetrix GeneChip
Chicken Genome Arrays were imported into GeneSpring
software and unfiltered differentially-expressed genes
(DEGs; FDR ≤ 0.01) identified for a preliminary hierarchical and k-means cluster analysis (Fig. 1 only).
Next, open-source R (version 3.3.3) [20] software packages, available from Bioconducter [21], were used for data
processing and statistical analysis of the single-channel
microarray data (raw cell files) obtained in this study. The
software package affylmGUI (version 1.48.0) was used to
perform normalization and to determine differential expression [22]. The robust multi-array average (RMA)
method [23] was applied for background correction, quantile normalization and output of gene expression values
on the log2 scale. Internally, affylmGUI uses the Linear
Model Fit of LIMMA package (version 3.30.13) to assess
differential expression of genes [24]. Statistical significance
was adjusted for multiple testing by controlling the
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Benjamini and Hochberg’s false discovery rate [25],
which was set at FDR ≤ 0.05. The Affymetrix chicken
annotation data package [26] was then used to annotate the differentially-expressed genes (DEGs). LIMMA
was used to make pairwise comparisons (contrasts) across
embryo and hatchling ages and to filter DEGs by the FDR
adjusted p-value (P ≤ 0.05) and a log2 ratio ± 0.75 cutoff.
This gene expression level threshold of log2 ratio ± 0.75
(or a 1.68-fold difference) has proven useful for statistical
analysis of microarray data in model plants [27].
Ingenuity pathways analyses

An annotated list of DEGs for each pairwise contrast
was then used as the input file for Ingenuity® Pathway
Analysis (IPA), which provides functional annotation,
mapping to canonical pathways and biological processes,
and identification of gene interaction networks [28]. The
DEGs accepted by IPA are considered as “Analysis Ready”
(AR)-DEGs, if the gene is curated and annotated in the
Ingenuity® Knowledge Base. However, the Ingenuity
Knowledge Base is mainly based on mammalian biomedical literature and rather void of avian-specific genes. We
used a combination of Human Genome Organisation

Fig. 1 This figure provides an initial visual analysis of gene expression patterns found in liver of 12 embryos (E16, E18 and E20) and 12 hatchlings
(D1, D3 and D9) during the critical embryo-to-hatchling transition. GeneSpring GX 7 software was only used for the preliminary analysis of
differentially-expressed (FDR ≤ 0.01) genes (DEGs) and visualization of expression patterns from hierarchical (a) and k-means cluster (b) analyses. The
heat map in Panel a clearly shows three distinct expression patterns of DEGs: Cluster A (high in embryos, low in hatchlings), Cluster B (low in embryos,
high in hatchlings) and Cluster C (mixed pattern). K-means clustering (Panel b) provides higher resolution of DEGs found in Cluster A, including two
examples: deiodinase 3 (DIO3) and monoacylclycerol O-acyltransferase 1 (MOGAT1), both have higher expression in embryos and lower abundance in
hatchlings. In contrast, Cluster B contains DEGs with lower expression in embryos [i.e., deiodinase 2 (DIO2)] and much greater (log-scale) abundance in
liver of hatchlings [i.e., thyroid hormone-responsive Spot 14 protein alpha (THRSPA)], especially in fully-fed D3 and D9 chicks
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(HUGO) gene symbol as the primary gene ID and the
RefSeq Protein ID as the secondary gene ID to maximize
the number of chicken DEGs accepted by IPA. The
AR-DEGs were mapped onto canonical pathways, biological processes and gene interaction networks. IPA uses
the Fisher’s Exact Test to indicate significance (P ≤ 0.05) of
over-representation of AR-DE genes in canonical pathways and biological processes. The Ingenuity® Upstream
Regulator Analysis was used to identify major transcription factors, their interaction with other upstream regulators, and their interactions with direct target genes to
predict either activation or inhibition of upstream regulators. Lists of annotated AR-DEGs were generated by IPA
and provided in Additional files.
Verification of differential gene expression by
quantitative RT-PCR analysis

A second aliquot of each total RNA sample from the 24
livers (above) was used for quantitative real-time PCR
(qRT-PCR) analysis. The expression of 15 DEGs identified by microarray analysis was verified by qRT-PCR
analysis (see Additional file 2). Selection of these candidate genes was based on their known function in pathways of interest or involvement in lipid metabolism. In
additional, a panel of three invariant genes (COX7A2L,
PCF11 and PRL14) was included in the qRT-PCR analysis
for normalization of qRT-PCR expression levels. Firststrand cDNA was synthesized using 1 μg of total RNA,
oligo-dT, random hexamer primers and SuperScript III
reverse transcriptase kit (Invitrogen Life Technologies,
Carlsbad CA). Primers used for qPCR were designed using
Primer Express (Applied Biosystems, Foster City, CA).
The qRT-PCR assay was performed for each sample in duplicate wells using Power SYBR green PCR master mix
(Applied Biosystems, Foster City, CA) and a gene-specific
primer-pair (Sigma-Genosys, Woodlands, TX) on an ABI
Prism Sequence Detection System 7900HT. Biogazelle
qbase+ software [29] was used for pre-processing raw
cycle threshold (Ct) data and the geNorm procedure for
normalization of relative gene expression levels. The expression stability of candidate genes and a panel of invariant “housekeeping” genes was based on the geNorm (M)
and coefficient of variation (CV) values across duplicate
measurements of the 24 liver RNA samples. Ribosomal
protein L14 (RPL14) and cytochrome c oxidase subunit
VIIa polypeptide 2-like (COX7A2L) were selected as optimal co-reference genes with a mean of M = 0.251 and CV
= 0.087. The PROC GLM in Statistical Analysis System
(SAS, v.9.4; Cary NC) was used to analyze all pairwise differences among ontogenic stages and control for multiple
comparisons using the option ADJUST = TUKEY. The
Pearson’s correlation procedure in Excel was used to compare the average relative expression levels of each candidate DEG obtained from microarray analysis with that
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obtained by qRT-PCR analysis. Relative expression levels
obtain by these two independent methods was verified by
a significant (P ≤ 0.01) Pearson’s correlation coefficient (r).

Results
Initial visualization of gene expression patterns using
GeneSpring® analysis

The preliminary GeneSpring analysis of the 24 Affymetrix arrays identified 4566 differentially-expressed genes
(DEGs; FDR ≤ 0.01) in the contrast of 12 embryos vs.12
hatchling chicks. The unsupervised hierarchical clustering of these unfiltered DEGs by GeneSpring provided a
visual image (heat map) of the most dramatic changes in
hepatic gene expression during the peri-hatch period
(Fig. 1a). This heat map shows three distinct patterns of
hepatic gene expression during the embryo-to-hatchling
transition. “Cluster A” DEGs are expressed at higher
levels in embryos (E16, E18 and E20) and at lower levels
after hatching, especially in fully-fed D3 and D9 hatchings. In contrast, the DEGs in “Cluster B” have a low
abundance in embryos and sharply elevated expression
in hatchlings, while “Cluster C” DEGs exhibit a mixed
pattern of gene expression. The second panel (Fig. 1b),
derived from k-means clustering, provides a higher
resolution of gene expression patterns in Cluster A
(1166 DEGs) and Cluster B (801 DEGs), with examples
of two predominant genes per cluster. Deiodinase 3
(DIO3) and monoacylglycerol O-acyltransferase 1
(MOGAT1) are highly expressed in liver of late embryos, whereas thyroid hormone-responsive Spot 14
protein alpha (THRSPA) and deiodinase 2 (DIO2) were
the most abundant DEGs found in liver of hatchling
chicks. K-means clustering provides identification of
individual genes and a high-resolution view of opposing expression patterns of the deiodinases (DIO2,
DIO3), which clearly shows the pivotal role that thyroid hormone metabolism plays in the metabolic jump
from ectotherm (embryos) to endotherm (hatchlings)
during the peri-hatch period.
Ingenuity pathway analysis (IPA): Identification of analysis
ready DEGS

The DEGs within each contrast were considered as
“Analysis Ready” (AR-DEGs) if accrued and curated in
the Ingenuity® Knowledge Base. The numbers of upregulated and down-regulated AR-DEGs are presented
for the14 pairwise contrasts in a split-bar graph (Fig. 2).
An annotated list of AR-DEGs in each pairwise contrast
is provided in Additional file 3. A primary contrast was
made between all embryos (E) vs. all hatchlings (H),
which identified 1272 AR-DEGs. The greatest number of
AR-DEGs (2440 hepatic genes) was found in the E18 vs.
D3 contrast, where 846 AR-DEGS were higher in E18
embryos (lipid-laden-ectotherms) and twice that number
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Venn diagram (Fig. 3d) represents exclusive contrasts of
hatchlings. The D1 vs. D3 contrast (643 AR-DEGs) was
made between newly-hatched, fasted chicks (D1) and fed
D3 hatchlings. The D1 vs. D9 hatchling contrast yielded
1036 AR-DEGs, 416 genes were shared with the D1 vs.
D3 contrast, and 228 AR-DEGs shared with the D3 vs.
D9 contrast of 403 AR-DEGs. And as expected, this
Venn diagram of hatchling contrasts had the lowest
number (42 genes) of commonly-shared AR-DEGs.
Ingenuity pathway analysis (IPA): Functional analysis of
each pairwise contrast
Embryo (E) vs. hatchling (H) contrast
Fig. 2 This stacked-bar graph provides the number of up-regulated
(red portion of bar) and down-regulated (green portion of bar) ARDEGs found by IPA in 14 pairwise contrasts of liver transcriptomes
from embryos (E) and hatchlings (H). The list of annotated DEGs
(FDR ≤ 0.05) for each developmental age was used to make 14
meaningful pairwise contrasts across embryos and hatchlings ages.
An Excel file was generated for each contrast, and subsequently
used as the input file for Ingenuity® Pathway Analysis (IPA). “Analysis
Ready” (AR) genes are DEGs (AR-DEGs) that map to the Ingenuity®
Knowledge Base. An annotated list of AR-DEGs for each of the 14
contrasts is provided in Additional file 3

(1594 AR-DEGs) was found in liver of fully-fed D3
hatchlings. When E16 embryos were compared against
either E18 (231AR-DEGs) or E20 (814 AR-DEGs) embryos, there were fewer genes compared to E16 embryos
versus D1 (1084 AR-DEGs) or D3 (1784 AR-DEGs)
hatchlings. The lowest number of AR-DEGs was found
at ends of the ontogenic spectrum (Fig. 2), namely E16
vs. E18 (231 AR-DEGs) and D3 vs. D9 hatchlings (403
AR-DEGs).
Venn diagrams provide unique and commonly-shared
sets of hepatic AR-DEGs among meaningful contrasts of
embryo and hatchling ages (Fig. 3). The Venn diagram
in Fig. 3a compared three contrasts: E vs. H, E16 vs. E20
embryos and D1 vs. D9 hatchlings. A group of 604
AR-DEGs were unique to the E vs. H contrast, which
shared 173 AR-DEGs with the E16 vs. E20 contrast and
313 AR-DEGs with the D1 vs. D9 contrast. The Venn
diagram in Fig. 3b shows larger numbers of AR-DEGs in
contrasts made between each embryonic age (E16, E18
and E20) vs. fully-fed D3 hatchlings. Also, this Venn diagram contains the largest number of commonly-shared
AR-DEGs (1004 genes) among contrasts between E16,
E18 and E29 embryos compared with the D3 hatchlings.
In Fig. 3c, E18 embryos were compared against E20 embryos, D1 or D3 hatchlings. Comparisons of E18 vs. E20,
D1 or D3 (Fig. 3c) revealed 372 common genes and a
large group of 1096 AR-DEGs that are unique to the
E18 vs. D3 contrast and an additional 914 AR-DEGs that
are shared with the E18 vs. D1 contrast. The fourth

A description of the IPA of each pairwise contrast follows the same order in which the pair-wise contrasts are
presented in Fig. 2 and Additional file 3. A brief summary of the IPA “Core Analysis” of 1272 AR-DEGs identified in the primary contrast of all embryos (E) vs. all
hatchlings (H) is provided in Table 1. The top five canonical pathways over-represented by AR-DEGs from
the E vs. H contrast were related to cholesterol biosynthesis, triacylglycerol biosynthesis, or activation of the
ligand-activated nuclear receptor, retinoid X receptor
(RXR) and its heterodimer partners [liver activated receptor (LXR) and farnesoid activated receptor (FXR)].
The top upstream regulator found in liver of embryos
was peroxisome proliferator-activated receptor-alpha
(PPARA), which is considered as the master regulator of
lipid catabolism, namely lipolysis of yolk lipids. It should
be noted that IPA estimates the top up-stream regulators
according to the number of target AR-DEGs in the data
set rather than whether or not the transcription factor
(TF) itself was differentially expressed. PPARA was an
AR-DEG that had 94 direct targets among the 1272
AR-DEGs. Sterol-response element binding factors 1
and 2 [SREBF1 (51 AR-DEG targets) and SREBF2 (28
AR-DEG targets) are ligand-activated transcription factors, which regulate sterol biosynthesis. Although not an
AR-DEG itself, the tumor protein p53 (TP53) had the
highest number of direct gene targets observed in the E
vs. H contrast. Similarly, fork-head box O1 (FOXO1), a
member of the fork-head family of transcription factors
was not an AR-DEG in the E vs. H contrast, although
IPA considered FOXO1 a top up-stream regulator due
to its large number of direct target genes in this contrast. Actually, 23 transcription factors (TFs) were
AR-DEGs in the E vs. H contrast, where 11 TFs were
expressed higher in liver of embryos and 12 TFs were
expressed higher in hatchlings (see Additional file 4). Of
particular interest, a recently discovered gene SERTA
domain containing 2 (SERTAD2 or TRIP-Br2) was
up-regulated in liver of embryos. SERTAD2 is a transcription co-regulator of lipolysis, thermogenesis and
oxidative metabolism in mammals.

Cogburn et al. BMC Genomics (2018) 19:695
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a

b

c

d

Fig. 3 These Venn diagrams represent comparisons made from 12 meaning pairwise contrasts of hepatic transcriptomes across embryo and
hatchling ages. The Venn diagrams show the number of unique genes and the number of commonly shared genes found in pairwise contrasts
of hepatic transcriptomes. The Venn diagram in Panel a compares all embryos (E) vs. all hatchlings (H), E16 vs. E20 embryos, and D1 vs. D9 hatchlings.
Panel b shows a Venn diagram comparing E16, E18 or E20 embryos vs. D3 hatchlings. Panel c shows the comparison of E18 embryos vs. E20, D1 or
D3. Panel d illustrates shared and common genes among hatchling ages (D1 vs. D3, D1 vs. D9, and D3 vs. D9). The number of AR-DEGs found in each
contrast is shown in brackets. The number within arcs represents genes commonly-shared between and among contrasts

The top “Molecular and Cellular Functions”, found in
the E vs. H contrast (Table 1), were “Small Molecule
Biochemistry” (358 AR-DEGs), “Lipid Metabolism” (284
AR-DEGs), and “Molecular Transport” (231 AR-DEGs).
Fifty AR-DEGs were functionally annotated by IPA as involved in “Amino Acid Metabolism”, where 28 genes
were overexpressed in liver of embryos compared to 22
genes in this category expressed higher in hatchlings
(Additional file 4). “Oxidation of Lipid” was another IPA

“Biofunction” category that was over-represented by 40
metabolic AR-DEGs in the E (19 genes) vs. H (21 genes)
contrast. “LPS/IL1 Mediated Inhibition of RXR Function”
was another canonical pathway occupied by AR-DEGs
from the embryo vs. hatchling contrast; 13 genes were
more abundant in embryos and 19 genes were higher in
liver of hatchlings. Hepatic genes involved in “Cholesterol
Biosynthesis” are more numerous in liver of hatchlings
(16/17 AR-DEGs), where only HADHB was expressed
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Table 1 Ingenuity Pathway Analysis (IPA) of the liver transcriptome in the E vs. H contrast
Top Canonical Pathways

p-value

Overlap

Ratio

Super-pathway of Cholesterol Biosynthesis

1.00E-12

73.9%

17/23

Cholesterol Biosynthesis I-III

1.29E-08

90.0%

9/10

LXR/RXR Activation

1.24E-07

33.3%

24/72

FXR/RXR Activation

1.14E-07

31.6%

25/79

Triacylglycerol Biosynthesis

1.29E-06

43.8%

14/32

Top Upstream Regulators
PPARA

p-value of overlap

# Target genes

1.00E-26

94

SREBF1

5.15E-17

51

TP53

8.71E-16

186

SREBF2

2.88E-14

28

FOXO1

4.25E-12

74

p-value

# Genes

Top Molecular and Cellular Functions
Amino Acid Metabolism

1.97E-03 - 6.58E-14

72

Small Molecule Biochemistry

1.97E-03 - 6.58E-14

358

Lipid Metabolism

1.97E-03 - 2.36E-13

284

Molecular Transport

1.82E-03 - 2.36E-13

231

Vitamin and Mineral Metabolism

1.13E-03 - 3.43E-12

88

Physiological System Development and Function

p-value

# Genes

Tissue Morphology

1.50E-03 - 1.28E-06

186

Organismal Development

1.87E-03 - 1.63E-06

373

Organ Morphology

1.16E-03 - 4.30E-06

123

Renal and Urological System Development and Function

1.13E-03 - 4.30E-06

66

Embryonic Development

1.87E-03 - 1.19E-05

195

Toxicity Functions
LXR/RXR Activation

p-value

# Genes

Ratio

1.67E-07

32.9%

24/73

FXR/RXR Activation

2.14E-07

31.6%

25/79

Cholesterol Biosynthesis

2.69E-07

66.7%

10/15

LPS/IL-1 Mediated Inhibition of RXR Function

2.95E-05

22.1%

32/145

Liver Necrosis/Cell Death

5.92E-05

19.3%

42/218

log2 Ratio (E/H)

Top Down-regulated genes

log2 Ratio (E/H)

Top Up-regulated genes
MOGAT1

5.44

THRSPA

−7.15

DIO3

5.01

SLCO1A2

−5.82

PPM1K

4.65

ELOVL5

−5.60

PDK4

3.95

CDO1

−5.23

SLC13A3

3.82

FASN

−5.08

ITGBL1

3.66

SQLE

−4.92

TTLL2

3.64

DIO2

−4.84

ALKAL2

3.18

NSDHL

− 4.74

RET

3.16

CYP7A1

−4.73

ASCL1

3.11

AFMID

−4.44

Ingenuity Pathway Analysis (IPA) provided a functional analysis of 1272 “Analysis Ready” (AR) and differentially expressed genes (AR-DEGs) in the
embryo vs. hatchling contrast. The P-values were derived by IPA from Fisher’s Exact Test, which indicates the likelihood of over-representation of ARDEGs in particular canonical pathways and biological processes. The top 10 up-regulated genes in embryo (E) liver have positive E/H ratios, whereas the
10 down-regulated genes possess negative log2 ratios (E/H) which indicates higher expression in hatchling (H) liver
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greater in embryos. “Triacylglycerol Synthesis” was
also over- represented with 14 AR-DEGs, 6 genes
(mainly acyltransferases) were higher in liver of embryos and 8 genes (3 acyltransferases and 3 fatty acid
elongases) were expressed a greater levels in hatchlings. Four additional over-represent canonical pathways populated by AR-DEGs from the E vs. hatchling
contrast included farnesoid X-activated receptor (“FXR)RXR Activation” (25 AR-DEGs), liver activated receptor
(“LXR-RXR Activation” (24 AR-DEGs), thyroid hormone
receptor (“TR-RXR Activation” (16 genes), and the
“Coagulation System” (5 genes expressed higher in
embryos and one gene higher in hatchlings).
The importance of hepatic lipid metabolism during
the embryo-to-hatchling transition becomes clear by
examining the subcellular distribution of 149 AR-DEGS
that control “Lipid Synthesis” (Fig. 4.). This graphic overview shows higher expression of 54 AR-DEGs (red symbols) in the liver of embryos, while twice that number (95
AR-DEGs) were expressed higher in hatchlings (green
symbols). In the nucleus, seven TFs were expressed higher
in liver of embryos PROX1, SIRT1, PPARGC1A, TFC2L1,
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RGN, PPARA and NR1H4). Likewise, seven TFs were
expressed higher in liver of hatchlings (PPARG, SREBF2,
BRCA1, KLF11, THRSPA, LPIN1 and CASP8). Thus, Ingenuity® Up-stream Regulator Analysis predicts that lipid
synthesis was inhibited in liver of hatchlings when compared to the embryos (red symbols) as indicated by
blue-dashed lines. However, the over-abundance of genes
with green symbols (62 AR-DEGs) found in the cytoplasm
are metabolic enzymes, transporters, kinases and phosphatases, which are actually expressed at higher levels in
liver of hatchlings than in embryos (only 22 up-regulated
genes). Among the most abundant cytosolic genes found
in the embryo were several lipolytic AR-DEGs: MOGAT1,
PDK4), FDXR, LPL, HMOX2, PTGDS and DAB1. Notable
and highly-expressed lipogenic DEGs were found in the
liver of hatchlings, including SCD, FASN, ME1, AGPAT2,
LSS, ACACA, ELOVL5 and ELOVL6. In the plasma membrane, 17 DEGs were expressed at high levels in hatchlings
(i.e., FADS1, FADS2, DDP4, PLIN2, ENPP2 and LDLR),
while the GHR, TNFRSF1B, ENDRA and EGFR were
upregulated in embryos. Extracellular space was occupied by 12 gene products expressed higher in the

Fig. 4 This figure provides the subcellular distribution of 149 hepatic AR-DEGs that regulate “Synthesis Lipid” from the contrast of all embryos vs.
all hatchlings. Higher gene expression in embryos is indicated by red symbols and AR-DEGs with higher expression in liver of hatchlings have
green symbols. However, the Ingenuity Upstream Regulator Analysis predicts that lipid synthesis would be inhibited in embryos as indicated by the blue
label and blue dashed lines. This IPA prediction is based on actual E/H expression ratios and the observation that the number of AR-DEGs with higher
expression in hatchlings (denominator) is 2-times greater than that of embryos (numerator). A small group of 14 transcription factors controls a much
larger group of downstream metabolic genes. The largest number of AR-DEGs was found in “Cytoplasm”; these genes encode metabolic enzymes, kinases,
phosphatases and transporters. The “Plasma Membrane” is mainly composed of genes encoding transmembrane and G-protein coupled receptors,
transporters, enzymes, kinases and phosphatases. The extracellular AR-DEGs are a mixture of growth factors, adipokines, cytokines and transporters
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embryo (i.e., APOB, ADIPOQ, IGFBP2, TNFSF10, IPC,
F2, HGF, LCAT, CETP, CXCL12 and BMP5) when compared to only 5 hepatic gene products that were higher in
extracellular space of the hatchlings (APOA4, EREG,
NPC2, ANG and FGF23). This subcellular distribution of
149 AR-DEGs from the E vs. H contrast provides a comprehensive view of how 14 differentially-expressed TFs
control lipid synthesis, while revealing major lipolytic
genes in embryos and an even larger number of lipogenic
genes in liver of hatchlings.
Another interaction network the E vs. H contrast was
functionally annotated by IPA as “Lipid Metabolism,
Molecular Transport” (Fig. 5). This network shows interactions among three lipogenic TFs (THRSPA, PPARG and
SREBF2) and their direct target genes. The ligandactivated nuclear hormone receptor PPARG has a direct
action on five target genes that were highly expressed in
embryos (IDH1, FABP5, MANBA, PDK4 and CPT1A). In
addition, PPARG interacts with several genes that are
more abundant in liver of hatchling chicks (SCD,
THRSPA, EVOLV6, HMGCR, FABP7, GARNl3, ADIPOR2, VNN1, LPIN1 and FDPS). LPIN1 interacts with
LPIN2, PLPP3 and FDPS, which has a direct action on
FNTB and GGPS1. Six genes in this network have direct interactions with both PPARG and SREBF2 (FDPS,
SCD, THRSPA, ELOVL6, HMGCR and IDH1). Numerous additional direct targets of SREBF2 from the E vs.
H contrast were identified by the Ingenuity® Upstream
Regulator Analysis (Fig. 5b), which predicts that the
majority of these 28 target genes would be inhibited
(or down-regulated, as indicated by blue arrows) by
SREBF2. Ingenuity only predicts that the LDL receptor
related protein 1 (LRP1), which was up-regulated in
embryos, would be inhibited by SREBP2 as indicated
by the blunt orange line. However, two additional
genes that were also highly abundant in the embryo,
IDH1 and FABP5, appeared to be inconsistent with
IPA’s anticipated state. Interestingly, SREBF2 and its
direct target genes are involved in cholesterol metabolism and lipogenesis in particular, which are both enhanced in liver of hatchling chicks. As direct targets of
SREBF2, only LRP1, IDH1 and FABP5 were up-regulated
in liver of embryos. Furthermore, 26 of the most abundant
AR-DEGs found in liver of hatchling chicks (Additional
file 4) are involved in either cholesterol biosynthesis (i.e.,
MSMO1, MVD, CYP8B1 and DHCR7) or lipogenesis (i.e.,
FADS2, FASN, HMGCS1, LPIN2 and ACACA).
The gene interaction network in Fig. 6a, found in the
E vs. H contrast, was functionally annotated by IPA as
“Hematological System Development and Function”. This
network was centered on interaction of several blood clotting factors (TFPI, F2, F11, PROC and PROZ) with two
lipolytic TFs (PPARGC1A and SIRT1) and with components of the glutathione transferase pathway (GSTA1,
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GSTA2, GSTO1, GSTZ1, MGST3, GPX3 and GPX8). Ingenuity® Up-stream Regulator Analysis also identified 24
target genes of SIRT1 (Fig. 6b), which would either activate
several genes in embryos (CPT1A, HGF, NR1H4, PDK4,
PPARGC1A, TFP1, ADIPOQ and CDH2) or inhibit other
genes in (CDKN2B, FASN, H2AFZ and HMGCR). These
genes are highly expressed in liver of embryos and directed
at lipolysis and gluconeogenesis, while the AR-DEGs with
green symbols are mainly lipogenic genes.
E16 vs. E18 contrast

The E16 vs E18 contrast yielded the smallest number (231)
of AR-DEGs (Fig. 2; Additional file 3), which prevented
generation of highly-populated gene interaction networks
by IPA. Interestingly, the most abundant DEGs expressed
in the liver of E16 embryos when compared to E18 embryos were seven transcripts that correspond to feather
keratin (FKER). Unfortunately, these avian-specific transcripts were rejected by Ingenuity software and not included in the IPA functional analysis of the E16 vs. E18
contrast.
E16 vs. E20 contrast

The contrast of E16 vs. E20 embryos identified 814
AR-DEGs, which included 514 genes up-regulated in
E16 liver (Additional file 3). A summary of the IPA of
the liver transcriptome of E16 vs. E20 embryos is presented in Table 2. The top five canonical pathways
over-populated by 814 AR-DEGs in this contrast were
“LPS/IL-1 Mediated Inhibition of RXR Function, Mitotic
Roles of Polo-Like Kinase, Complement System, Tyrosine Degradation I, and Cell Cycle Control of Chromosomal Replication”. The top upstream regulators identified
by IPA from this contrast were E2F4, TCF3, PPARA, E2F1
and TCF4. The top “Molecular and Cellular Functions” recognized in the E16 vs. E20 contrast were “Cell Cycle”, “Cellular Assembly and Organization”, “DNA Replication,
Recombination, and Repair”, “Cell Death and Survival”, and
“Cell Morphology”. The top “Physiological Function” category included the “Reproductive” and “Digestive” systems,
“Organ Morphology”, “Organismal Development” and “Behavior”. Under “Toxicity Functions”, IPA assigned several
AR-DEGs to “Inhibition of RXR Function”, fatty acid metabolism, renal failure, and transmembrane potentials.
Interestingly, the hepatic deiodinases were the top 10 opposing DEGs discovered in the liver of E16 (DIO3; + 3.6
log2 ratio) vs. E20 (DIO2; − 7.2 log2 ratio) embryos. Another gene highly expressed in liver of E16 embryos was
angiopoietin-like protein 3 (ANGPTL3), a regulator of
lipoprotein lipase. Serpin family A member 3 (SERPINA3), HPX, FABP1 and KLF9 were DEGs that were
up-regulated in liver of E20 embryos. Of particular
interest, the E18 vs. E20 contrast revealed higher expression of three Kruppel-like factors (KLF9, log2–3.52;
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a

b

Fig. 5 A gene network (Panel a) identified by IPA from the contrast of embryos (E) vs. hatchlings (H) that shows interaction of three lipogenic
transcription factors (THRSPA, PPARG, SREBF2) with several direct target genes. This gene network was functionally annotated by IPA as involved in
“Lipid Metabolism”. The legend provides a gene’s type while its relative expression (log2 ratio of E/H) indicates either higher expression in the
embryo (red symbols) or a greater abundance in liver of hatchlings (green symbols). Panel b, Ingenuity® Upstream Regulator Analysis identified
28 direct targets of sterol response element binding factor 2 (SREBF2); most of which were expressed at higher levels in hatchlings. Ingenuity
Upstream Regulator Analysis predicts inhibition of SREBF2, since 22 known direct targets of SREBF2 were downregulated (green symbols) in the E
vs. H contrast. Actually, genes with green symbols are more abundant in liver of the hatchlings, since they have negative log2 E/H ratios

KLF11, log2–0.85; KLF13, log2–2.31) in liver of E20 embryos (Additional file 3).
E16 vs. D1 contrast

The contrast of E16 embryos vs. D1 hatchlings recognized 1084 AR-DEGs, where 593 AR-DEGs were

more abundant in liver of the E16 embryos (Fig. 2;
Additional file 3). The highest DEGs found in embryo liver from the E16 vs. D1 contrast included
DIO3 and MOGAT1, while DIO2 and FABP1 were
among the highest AR-DEGs found in fasted D1
hatchlings.
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a

b

Fig. 6 A gene interaction network identified by IPA from the E vs. H contrast and functionally annotated as “Hematological System Development
and Function”. This gene network (Panel a) is centered on direct interactions of two transcription regulators [PPARG coactivator 1 alpha (PPARGC1A)
and sirtuin 1 (SIRT1)] with several blood clotting factors [tissue factor pathway inhibitor (TFPI); coagulation factor II, thrombin (F2); coagulation factor XI
(F11); protein C, in-activator of coagulation factors Va and VIIIa (PROC); and protein Z, vitamin K-dependent plasma glycoprotein (PROZ)] and with
components of the glutathione transferase pathway (GSTA1, GSTA2, GSTO1, GSTZ1, MGST3, GPX3 and GPX8). Panel b shows 24 direct targets of SIRT1
that were identified by Ingenuity® Up-stream Regulator Analysis, which predicts activation of SIRT1 since 17 of its known direct targets are upregulated
in embryos. Orange arrows show genes that are up-regulated by SIRT1, while blunt blue edges indicate inhibition of known target genes, as predicted
by Ingenuity software. Blue blunt lines predicts that activated SIRT1 would lead to inhibition of four known targets [cadherin 2 (CDH2) or inhibition
[cyclin dependent kinase inhibitor 2B (CDKN2B); fatty acid synthase (FASN); H2A histone family member Z (H2AFZ); and 3-hydroxy-3-methylglutaryl-CoA
reductase (HMGCR)]. Dark grey arrows identify several SIRT1 target genes, where an effect could not be predicted by IPA

E16 vs. D3 contrast

The E16 vs. D3 contrast identified 1784 AR-DEGs with
852 transcripts up-regulated in liver of E16 embryos
compared with 932 AR-DEGs in D3 hatchlings. DIO3

and MOGAT1 were also among the highest DEGs in E16
embryos from the E16 vs. D3 contrast whereas DIO2
and THRSPA were overexpressed DEGs found in liver of
D3 hatchlings.
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Table 2 IPA summary of the liver transcriptome in the E16 vs. E20 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

LPS/IL-1 Mediated Inhibition of RXR Function

4.21E-06

17.9%

24/134

Mitotic Roles of Polo-Like Kinase

8.94E-06

26.5%

13/49

Complement System

9.91E-06

37.5%

9/24

Tyrosine Degradation I

8.12E-05

80.0%

4/5

Cell Cycle Control of Chromosomal Replication

1.23E-04

23.9%

11/46

Top Upstream Regulators

p-value of overlap

# Target genes

E2F4

2.52E-23

52

TCF3

1.14E-19

56

PPARA

1.54E-15

57

E2F1

1.98E-15

62

TCF4

6.52E-14

36

p-value

# Genes

1.35E-03 - 7.51E-18

212

Top Molecular and Cellular Functions
Cell Cycle
Cellular Assembly and Organization

1.02E-03 - 7.51E-18

118

DNA Replication, Recombination, and Repair

1.02E-03 - 7.51E-18

150

Cell Death and Survival

1.33E-03 - 1.54E-11

350

Cell Morphology

2.22E-04 - 1.71E-11

74

Physiological System Development and Function

p-value

# Genes

Reproductive System Development and Function

5.11E-04 - 2.03E-06

23

Digestive System Development and Function

4.37E-04 - 7.57E-05

18

Organ Morphology

4.37E-04 - 7.57E-05

21

Organismal Development

4.37E-04 - 7.57E-05

142

Behavior

1.52E-04 - 1.52E-04

18

Top Toxicity Functions

p-value

# Genes

Ratio

LPS/IL-1 Mediated Inhibition of RXR Function

1.70E-05

16.6%

24/145

Fatty Acid Metabolism

6.31E-05

21.2%

14/66

Cell Cycle: G2/M DNA Damage Checkpoint Regulation

2.09E-04

24.4%

10/41

Genes Upregulated in Response to Chronic Renal Failure

1.02E-03

75.0%

3/4

Transmembrane Potential of Mitochondria and Membrane

1.50E-03

16.5%

13/79

log2 Ratio

Top Down-regulated Genes

log2 Ratio

Top Up-regulated Genes
DIO3

3.65

DIO2

−7.19

ACMSD

3.65

SERPINA3

−5.55

ANGPTL3

3.62

HPX

−4.61

HDAC9

3.35

FKBP5

−4.37

GAS2

3.19

CA4

−4.20

CHODL

3.11

FABP1

−4.07

CKS2

3.02

KLF9

−3.64

CKAP2

2.97

IP6K2

− 3.61

AURKA

2.93

SLCO1A2

−3.60

KPNA2

2.90

ITIH3

−3.49

Ingenuity Pathway Analysis (IPA) analysis of 814 “Analysis Ready” (AR) and differentially expressed (DE) genes (AR-DEGs) from the E16 vs. E20
contrast. The top 10 up-regulated genes in E16 liver have positive log2 ratios (E16/E20), whereas the 10 down-regulated genes possess negative
log2 ratios (E16/E20), which indicates higher expression in liver of E20 embryos
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E18 vs. E20 contrast

A total of 624 AR-DEGs were identified by the E18 vs.
E20 contrast, where 258 AR-DEGs were expressed at
higher levels in E18 embryos compared to 366 AR-DEGs
overexpressed in the E20 embryos (Table 3). The major
canonical pathways highly populated by AR-DEGs from
this contrast were “LPS/IL-1 Mediated Inhibition of
RXR Function, Mitotic Roles of Polo-Like Kinase, Protein
Ubiquitination Pathway, Unfolded Protein Response”, and
“Tyrosine Degradation I”. The top five upstream regulators found in the E18 vs. E20 contrast included PPARA,
TCF3, ATF6, FOXO3 and RARA. “Small Molecule Biochemistry” and “Cell Cycle” were the highly represented
molecular and cellular functions according to IPA. Likewise, “Organ Morphology” and “Organismal Development” were highly populated physiological functions
identified by IPA. Among the top toxicology categories
were “Fatty Acid Metabolism”, inhibition/activation of
RXR and “Cell Cycle”. Similar to the E16 vs. E18 contrast,
the thyroid hormone deiodinases were the most abundant
DEGs in E18 (DIO3; log2 + 3.8) vs. E20 (DIO2; log2–5.6)
contrast. Several additional genes, highly expressed in the
E20 liver, are involved in lipid metabolism (SERPINA3,
HMGCS1 and KLF9) or fatty acid transport (FABP1). Lists
of functionally-annotated hepatic AR-DEGs belonging
to these canonical pathways and biological functions
are provided in worksheets of Additional file 5. “Lipid
Synthesis” was a subcategory under “Lipid Metabolism” that was over-populated by 60 AR-DEGs; 18
DEGs were up-regulated in E18 embryos, whereas 42
hepatic genes were expressed at higher levels in liver
of E20 embryos. Under “Amino Acid Metabolism”, 21
AR-DEGs were more abundant in E18 embryos, while
12 genes were expressed higher in E20 embryos.
Under the “Insulin Resistance” category, IPA identified
12 AR-DEGs that were more abundant in E18 embryo
liver, while 16 genes were more abundant in E20 than
in E18 embryos. Nineteen AR-DEGs were assigned by
IPA to the “Sirtuin Signaling” pathway, where 14
AR-DEGs were higher in E20 embryos. The “FXR-RXR
Activation” pathway was occupied by 11 AR-DEGs,
where 7 genes were more abundant in E20 embryos.
This gene interaction network (Fig. 7) from the E18 vs.
E20 contrast was functionally annotated by IPA as “Lipid
Metabolism”. In liver of late chicken embryos, the interactions among four nuclear hormone receptors (NROB2,
ESRRG, PPARA and PPARGC1A) control energy balance
and lipid metabolism. Ingenuity predicts PPARGC1A
itself is inhibited (blue symbol) and blue arrows show
inhibition of target genes in the E18 vs. E20 embryos
(Fig. 7b). Fifteen direct targets of PPARGC1A (green
symbols) are highly expressed in liver of E20 embryos,
whereas red-colored gene symbols indicate up-regulated
expression in liver of E18 embryos. These genes (i.e.,

Page 14 of 37

INSIG1, NR1H4 and PPARA) are involved in fat catabolism, while genes with green-colored symbols indicate
higher expression of lipogenic genes in E20 embryos. In
addition, Ingenuity predicts activation of the orphan receptor NROB2 (nuclear receptor subfamily 0 group B
member 2), which leads to inhibition (blunt blue lines) of
seven lipogenic genes (PPARGC1A, ANOX1, CPT1A,
CTP8B1, EGR1, ESRRG and HMGCR). Another direct target of NROB2 (an inhibitor of estrogen, thyroid and retinoid nuclear hormone receptors) was the ligand-activated
transcription factor NR1H4, which is activated by bile
acids and thereby controls expression of genes involved in
bile acid synthesis and transport. NR1H4 is also a direct
target of PPARGC1A.
E18 vs. D1 contrast

The functional analysis of 1591 AR-DEGs found in the
E18 vs. D1 contrast is presented in Table 4. The major
canonical pathways identified by IPA in this contrast
were “NRF2-mediated Oxidative Stress Response” and
“Hereditary Breast Cancer Signaling”. The largest number of direct target genes was associated with two TFs,
TP53 and ESR1. The top “Molecular and Cellular Functions” recognized by IPA of the E18 vs. D1 contrast were
“Cell Cycle”, “Cellular Assembly and Organization”,
“DNA Replication, Recombination, and Repair”, “Cell
Death and Survival”, and “Lipid Metabolism”. Under the
category “Physiological System Development and Function”, the largest number of DEGs was assigned to “Embryonic Development”. The top “Toxicity Functions”
were related to the oxidative stress response, liver necrosis/proliferation and RXR activation. The highest DEGs
in liver of E18 embryos were DIO3 and MOGAT1, while
in D1 hatchling chicks the most abundant transcripts
were involved in lipid metabolism (DIO2, ELOVL5,
FABP1 and HMGCS1). Furthermore, four members of
the Kruppel-like transcription factors (KLF9, KLF11,
KLF13 and KLF15) were abundant DEGs found in liver
of fasted D1 hatchlings (Additional file 3).
E18 vs. D3 contrast

The largest number of AR-DEGs was found in the E18 vs.
D3 contrast (2440 AR-DEGs), which overpopulated the
cholesterol and triacylglycerol biosynthetic pathways, and
the “Intrinsic Prothrombin Activation Pathway” where all
12 AR-DEGs were up-regulated in liver of E18 embryos
(Table 5). The top “Up-stream Regulators” in the E18 vs.
D3 contrast included TP53, PPARA, and FOXO3. Among
the top “Molecular and Cellular Functions” identified by
IPA were the “Cell Cycle”, “DNA Replication, Recombination, and Repair”, “Small Molecule Biochemistry” (535
AR-DEGs; including 215 AR-DEGs that belong to the
“Lipid Synthesis” subcategory; see Additional file 6),
and “Cellular Assembly and Organization”. “Organismal
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Table 3 IPA summary of the liver transcriptome in the E18 vs. E20 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

LPS/IL-1 Mediated Inhibition of RXR Function

1.11E-04

13.4%

18/134

Mitotic Roles of Polo-Like Kinase

1.22E-04

20.4%

10/49

Protein Ubiquitination Pathway

4.53E-04

10.9%

22/202

Unfolded protein response

9.41E-04

19.0%

8/42

Tyrosine Degradation I

1.14E-03

60.0%

3/5

Top Upstream Regulators

p-value of overlap

# Target genes

PPARA

6.04E-14

47

TCF3

1.11E-11

38

ATF6

1.56E-08

13

FOXO3

5.68E-08

32

RARA

6.84E-08

30

Top Molecular and Cellular Functions

p-value

# Genes

Amino Acid Metabolism

2.43E-03 - 1.01E-12

42

Small Molecule Biochemistry

3.58E-03 - 1.01E-12

161

Cell Cycle

3.01E-03 - 5.43E-10

82

Cell Morphology

2.92E-03 - 1.29E-09

39

Cellular Assembly and Organization

2.92E-03 - 1.29E-09

43

Physiological System Development and Function

p-value

# Genes

Hematological System Development and Function

2.85E-03 - 2.16E-05

23

Lymphoid Tissue Structure and Development

2.43E-03 - 2.16E-05

17

Organ Morphology

2.43E-03 - 2.16E-05

55

Tissue Morphology

2.43E-03 - 2.16E-05

25

Organismal Development

3.07E-03 - 2.64E-05

68

Top Toxicity Functions

p-value

Overlap

Ratio

Fatty Acid Metabolism

7.84E-05

18.2%

12/66

LPS/IL-1 Mediated Inhibition of RXR Function

2.72E-04

12.4%

18/145

FXR/RXR Activation

1.62E-03

13.9%

11/79

Cell Cycle: G2/M DNA Damage Checkpoint Regulation

3.55E-03

17.1%

7/41

PXR/RXR Activation

3.55E-03

17.1%

7/41

log2 Ratio

Top Down-regulated Genes

log2 Ratio

DIO3

3.81

DIO2

−5.61

ANGPTL3

3.14

SERPINA3

−4.54

SLC2A5

2.99

FABP1

−3.93

RET

2.83

HIGD1A

−3.81

GAS2

2.70

HMGCS1

−3.78

HDAC9

2.69

KLF9

−3.52

NAV2

2.47

C6

−3.44

CHODL

2.46

HPX

−3.38

SLC13A3

2.45

FKBP5

−3.28

SOX9

2.36

SLCO1A2

−3.26

Top Up-regulated Genes

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 624 AR-DEGs identified in the E18 vs. E20 contrast (E18/E20 ratio). AR-DEGs
with positive log2 ratios are expressed higher in liver of E18 embryos, while negative log 2 ratios indicate higher expression in E20 embryos
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a

b

Fig. 7 This gene network (Panel a) from the E18 vs. E20 contrast was functionally annotated by IPA as “Lipid Metabolism”. It shows interactions
among four nuclear hormone receptors [nuclear receptor subfamily 0 group B member 2 (NROB2), estrogen related receptor gamma (ESSRG),
peroxisome proliferator-activated receptor-alpha (PPARA) and PPARGC1A] that regulate energy balance and lipid metabolism in liver of late embryos.
In Panel b, Ingenuity® Upstream regulator Analysis predicts that PPARGC1A itself is inhibited (blue symbol) because 16 known target genes are downregulated in the E18/E20 contrast. The blue arrows predict that 11 known target genes should be inhibited. Actually, red-colored gene symbols indicate
higher expression in liver of E18 embryos, whereas the green-colored symbols show higher expression in E20 embryos. In addition, Ingenuity predicts
that activated NROB2 leads to inhibition (blunt blue lines) of seven lipogenic genes (PPARGC1A, ANOX1, CPT1A, CTP8B1, EGR1, ESRRG and HMGCR),
whereas, the upregulation of NR1H4 is inconsistent with its expected state (based on the Ingenuity Knowledge Base)

Survival” was the most populated physiological function
found with this contrast. The top “Toxicity Functions”
assigned to AR-DEGs from the E18 vs. D3 include
“Cholesterol Biosynthesis”, NRF2-Mediated Oxidative
Stress Response, “LXR/RXR Activation”, and “TR/RXR
Activation”. The top 10 “Up-regulated Genes” in E18

embryos were DIO3, MOGAT1 and PDK4, whereas
lipogenic genes (THRSPA, SQLE, ELOVL5, DIO2, FASN
and SCD) were highly expressed in liver of fully-fed D3
hatchlings. The E18 vs. D3 contrast revealed seven
members of the Kruppel-like transcription factor family
as AR-DEGs (Additional files 3 and 6).
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Table 4 IPA summary of the liver transcriptome in the E18 vs. D1 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

Cell Cycle Control of Chromosomal Replication

9.58E-07

41.3%

19/46

Mitotic Roles of Polo-Like Kinase

5.36E-05

34.7%

17/49

NRF2-mediated Oxidative Stress Response

5.68E-05

24.3%

36/148

Role of BRCA1 in DNA Damage Response

6.89E-05

30.4%

21/69

Hereditary Breast Cancer Signaling

2.05E-04

24.8%

29/117

Top Upstream Regulators

p-value of overlap

# Target genes

TP53

3.51E-20

228

E2F4

1.61E-17

63

E2F1

5.07E-17

96

ESR1

2.04E-14

193

TCF3

1.50E-12

67

Top Molecular and Cellular Functions

p-value

# Genes

Cell Cycle

1.11E-03 - 8.65E-14

366

Cellular Assembly and Organization

1.11E-03 - 8.65E-14

276

DNA Replication, Recombination, and Repair

1.11E-03 - 8.65E-14

265

Cell Death and Survival

1.07E-03 - 4.85E-13

626

Lipid Metabolism

1.11E-03 - 1.49E-07

252

Physiological System Development and Function

p-value

# Genes

Embryonic Development

1.11E-03 - 1.20E-05

140

Organismal Survival

1.20E-05 - 1.20E-05

36

Reproductive System Development and Function

5.21E-04 - 1.87E-05

27

Hematological System Development and Function

1.09E-03 - 5.24E-05

27

Hematopoiesis

1.09E-03 - 5.24E-05

21

Top Toxicity Functions

p-value

Overlap

Ratio

NRF2-mediated Oxidative Stress Response

7.48E-06

25.2%

41/163

Liver Necrosis/Cell Death

2.94E-04

20.9%

46/220

Liver Proliferation

7.86E-04

21.1%

38/180

FXR/RXR Activation

1.43E-03

24.3%

20/79

LXR/RXR Activation

3.31E-03

24.7%

18/73

Top Up-regulated Genes

log2 Ratio

Top Down-regulated Genes

log2 Ratio

DIO3

4.82

SLCO1A2

−6.69

SLC13A3

4.67

DIO2

−5.44

MOGAT1

4.44

ELOVL5

−4.96

RET

4.37

COCH

−4.96

TTLL2

4.25

FABP1

−4.63

ASCL1

3.94

HIGD1A

−4.63

PPM1K

3.93

HPS5

−4.63

ALKAL2

3.76

SLC51A

−4.60

TFPI

3.47

CYP7A1

−4.54

ATP2B2

3.35

HMGCS1

−4.46

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 1591 AR-DEGs identified in the E18 vs. D1 contrast (E18/D1). AR-DEGs with
positive log2 ratios are expressed higher in liver of E18 embryos, whereas negative log2 ratios indicate higher expression in D1 hatchlings
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Table 5 IPA summary of the liver transcriptome in the E18 vs. D3 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

Superpathway of Cholesterol Biosynthesis

2.07E-08

73.9%

17/23

Cholesterol Biosynthesis I-III

3.03E-06

90.0%

9/10

Cell Cycle Control of Chromosomal Replication

4.22E-05

45.7%

21/46

Intrinsic Prothrombin Activation Pathway

6.93E-05

60%

12/20

Triacylglycerol Biosynthesis

8.97E-05

50%

16/32

Top Upstream Regulators

p-value of overlap

# Target genes

TP53

1.00E-21

318

PPARA

5.67E-18

115

E2F1

9.13E-17

125

E2F4

5.54E-15

75

FOXO3

3.82E-13

87

p-value

# Genes

Top Molecular and Cellular Functions
Cell Cycle

1.57E-03 - 2.09E-10

499

DNA Replication, Recombination, and Repair

1.38E-03 - 2.09E-10

345

Amino Acid Metabolism

1.57E-03 - 2.48E-10

79

Small Molecule Biochemistry

1.57E-03 - 2.48E-10

535

Cellular Assembly and Organization

1.38E-03 - 6.63E-10

326

p-value

# Genes

Organismal Survival

9.34E-04 - 8.88E-06

682

Embryonic Development

1.23E-03 - 3.36E-05

90

Tissue Morphology

1.57E-03 - 3.36E-05

207

Hematological System Development and Function

1.38E-03 - 1.83E-04

114

Organismal Development

1.30E-03 - 1.83E-04

191

Physiological System Development and Function

Top Toxicity Functions

p-value

Overlap

Ratio
10/15

Cholesterol Biosynthesis

8.13E-05

66.7%

NRF2-mediated Oxidative Stress Response

1.60E-04

31.3%

51/163

Liver Necrosis/Cell Death

2.67E-04

29.1%

64/220

LXR/RXR Activation

3.06E-04

37.0%

27/73

TR/RXR Activation

1.01E-03

34.6%

27/78

Top Up-regulated Genes
DIO3

log2 Ratio

Top Down-regulated Genes

log2 Ratio

6.62

THRSPA

−8.86

MOGAT1

6.38

SLCO1A2

−6.78

PDK4

5.35

SQLE

−6.71

PPM1K

5.32

CDO1

−6.64

RET

4.59

ELOVL5

−6.64

ITGBL1

4.43

DIO2

−6.64

ALKAL2

4.37

FASN

−6.48

TTLL2

4.14

NSDHL

−6.24

SLC13A3

4.05

SCD

−5.71

DNAJC12

3.89

CYP7A1

−5.65

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 2440 AR-DEGs identified in the E18 vs. D3 contrast (E18/D3 ratio). AR-DEGs
with positive log2 ratios are expressed higher in liver of E18 embryos, while negative log 2 ratios indicate higher expression in D3 hatchlings
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Two gene interaction networks depicted in Fig. 8 were
derived from IPA of a subset of 1004 commonly-shared
genes identified by the Venn diagram shown in Fig. 3b,
which compared contrasts of E16, E18 or E20 embryos vs.
D3 hatchlings. This subset of commonly-shared AR-DEGs,
enriched with multiple TFs and their direct target genes,
was functionally annotated by IPA as ‘Lipid Metabolism,
Molecular Transport, Small Molecule Biochemistry’

Page 19 of 37

(see Additional file 3; last worksheet). The top panel
(Fig. 8a) shows the interaction of three TFs (PPARA,
PPARG and PPARD) with several common target genes
(SIRT5, GPAM, PDK4, ALDH9A, ACSL, SLC27A4,
ELOVL6, ACOT8, CPT1A and PER3). The ligand-activated TF PPARA and its five direct targets (CPT1A,
SIRT5, CFI and LECT) were expressed at higher levels
in liver of E18 embryos. In contrast, PPARG and

a

b

Fig. 8 These two gene interaction networks were derived from a subset of 1004 commonly-shared genes found by comparing three contrasts
(E16, E18 or E20 embryos vs. D3 hatchlings (see Venn diagram in Fig. 3b). Both networks were overlaid with expression values from the E18 vs.
D3 contrast as indicated by the legend. This subset of commonly-shared AR-DEGs was enriched with multiple TFs and their direct target genes
and functionally annotated by IPA as ‘Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry’. The top panel (a) shows the interaction of
three major TFs (PPARA, PPARG and PPARD) with several common target genes. The second gene network (Panel b) shows the interaction of three TFs
(SREBF2, PPARGC1A and THRSPA). SREBF2 and its direct target genes, including THRSPA, were expressed higher in liver of D3 hatchlings. PPARGC1A and
THRSPA appear to have opposing actions on lipid metabolism as indicated by the blunt edge
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PPARD and 11 target genes are expressed higher in
liver of D3 hatchlings, to support lipogenesis and energy production of these fully-fed hatchlings. PPARG
has four unique direct target genes (ADIPOR2,
MANBA, GARNL3 and the collagen alpha 1 complex),
whereas PPARD has only four unique targets (MFSD2A,
LPIN2 and ST3GAL5) in this gene network. The second
gene network (Fig. 8b) shows the interaction of two major
lipogenic TFs (THRSPA and SREBF2; both expressed
higher in D3 hatchlings) with the transcriptional coactivator PPARGC1A, which was expressed higher in liver of
E18 embryos. Only five genes, directly or indirectly responsive to PPARGC1A were expressed at higher in liver
of E18 embryos, whereas SREBF2 and its 11 target genes,
including THRSPA, were more abundant in liver of D3
hatchlings. Most of the target genes of SREBF2 are involved in metabolism of cholesterol, sterol and ketones.
The contrast of E18 embryos vs. D3 hatchlings revealed another gene network of six transcription factors
(RORA, SMARCD3, ESRRG, NR1H4, PPARGC1A and
SREBF2) and their interactions with direct gene targets
that control “Lipid Metabolism” (Fig. 9a). Only SREBF2
was expressed higher in D3 hatchlings, where most of
its target genes are involved in lipid metabolism. The
RAR-related orphan receptor A (RORA; Fig. 9b) was
predicted by IPA to be inhibited (blue symbol) and
three target genes with blue arrows would be inhibited
(down-regulated; green symbols) when compared to
E18 embryos, which possessed only five up-regulated
target genes (IGFBP1, LPIN2, NTRK2, PPARGC1A and
AKR1D1). Ingenuity predicts that NR1H4 would be
slightly activated mainly due to presence of seven
DEGs (CETP, FABP5, LCAT, LIPC, NOS2, PPARA and
PPARGC1A) that were highly expressed in liver of the
E18 embryos. Ingenuity also predicts that upregulated
NR1H4 would inhibit lipid synthesis (i.e., ACACA,
CYP7A1 and FASN).
Another gene interaction network from the E18 vs, D3
contrast (Fig. 10a) was functionally annotated by IPA as
involved in “Cell Signaling” and under control of eight
interacting transcription factors (THRSP, NFYC, KAT2B,
KLF13, EAF1, EAF2, SOX7 and SOX8). The lipogenic
transcription factor THRSPA has direct interactions with
two other transcription regulators (NFYC and KAT2B).
In all, 12 genes in this network were expressed higher in
E18 embryos, whereas 18 AR-DEGs were over-expressed
in liver of D3 hatchlings. The second gene network
(Fig. 10b) involves interactions among six clotting factors (F5, F8, F9, F11, PROS1 and VWF), the growth factor gene MST1, collagen genes (COL1A1, COL3A1and
COL18A1) and components of the extracellular matrix
(FBLN1–2, LAMB1, LAMB3, LOX, SPARC and SOX17).
This connection of the extracellular matrix with F9 and
other coagulation factors is mediated by the direct
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interaction between two enzymes (HELLS and HSPD1).
Interestingly, most of the AR-DEGs in this network were
also expressed higher in liver of E18 embryos than D3
hatchlings. Furthermore, 12 coagulation factors (AR-DEGs)
belonging to the canonical “Intrinsic Prothrombin Activation Pathway” were up-regulated in liver of E18 embryos
(see Additional file 6).
E20 vs. D3 contrast

The E20 vs. D3 contrast identified 1775 AR-DEGs, whose
functional analysis is summarized in Table 6. The top canonical pathways occupied by these AR-DEGs were related to “Cholesterol Biosynthesis”, the “Complement
System”, “LXR/RXR Activation” and “Intrinsic Prothrombin Activation Pathway”. The top transcription regulators
in the E20 vs. D3 contrast were TP53, PPARA, E2F4,
E2F1 and FOXO3. Within the “Molecular and Cellular
Functions” category, IPA identified “Cell Cycle’, “Cellular Assembly and Organization”, DNA Replication, Recombination, and Repair”, “Lipid Metabolism”, and
“Small Molecule Biochemistry” as over-represented
sub-categories. Over-populated physiological functions
subcategories included “Organismal Survival”, “Connective Tissue Development” and “Tissue Morphology”. The top “Toxicity Functions” identified by IPA
included “LXR/RXR Activation, Cholesterol Biosynthesis, Fatty Acid Metabolism” and “FXR/RXR Activation”. Among the top 10 “Up-regulated Genes” in the E20
vs. D3 contrast were MOGAT1, PDK4, CPT1A (a major
regulator of fatty acid β-oxidation) and IGFBP2. The
highest DEGs found in the liver of D3 hatchlings are
involved in lipogenesis [THRSPA, SQLE, FASN, SCD,
ELOVL5 and FADS2).
D1 vs D9 contrast

Finally, the contrast of D1 vs. D9 hatchlings yielded
1036 AR-DEGs (Table 7; see Additional file 7). The top
canonical pathways identified by IPA were related to
cholesterol and stearate biosynthesis, the “Complement
System” and “LXR/RXR Activation”. The top upstream
regulators and their direct target genes found by IPA in
the D1 vs. D9 contrast were PPARA, TP53, E2F4, sterol
response element binding factor-2 (SREBF2) and TCF3.
Under the “Molecular and Cellular Functions” category,
the largest numbers of AR-DEGs were assigned to the
“Cell Cycle”, “Lipid Metabolism” and “Small Molecule
Biochemistry” subcategories. Under the “Physiological
Systems” category, the largest number of AR-DEGs in
the D1 vs. D9 contrast were found under “Connective
Tissue Development and Function” and Tissue Morphology. The top five “Toxicity Functions” were “Fatty Acid
Metabolism”, “Cholesterol Biosynthesis”, “LXR/RXR Activation”, “Cell Cycle: G2/M DNA Damage Checkpoint
Regulation” and “Liver Necrosis/Cell Death”. The “Lipid
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a

b

Fig. 9 Another gene network, functionally annotated by IPA as “Lipid Metabolism”, was identified in E18 vs. D3 contrast (a). This network shows
interactions among six up-stream regulators [RAR related orphan receptor A (RORA), SWI/SNF related, matrix associated, actin dependent regulator
of chromatin, subfamily d, member 3 (SMARCD3), ESRRG, NR1H4 (or farnesoid X receptor, FXR), PPARGC1A and SREBF2]. Ingenuity Upstream Regulator
Analysis predicts inhibition of RORA (Panel b), since the majority of its target genes are down-regulated (green symbols) in the E18 vs. D3 contrast. The
blue arrows directed at three lipogenic genes (FASN PLIN2 and SCD) predict inhibition by RORA. However, RORA and five direct targets (IGFBP1, LPIN2,
PPARGC1A and AKR1D1) are up-regulated in the E18 vs. D3 contrast as indicated by red gene symbols. Further, Ingenuity predicts that NR1H4 would be
slightly activated, which would lead to activation (orange arrows) of four target genes (CETP, LCAT, LIPC and PPARA), although seven target genes are
actually expressed at higher levels in liver of E18 embryos

Synthesis” subcategory contained 134 AR-DEGs, 53
were up-regulated in fasted D1 hatchlings and 81
genes were expressed higher in liver of fed D9 hatchlings (see Additional file 7). Three over-represented

canonical pathways were related to AR-DEGs controlling
“RXR Function”; these were “LPS/IL1 Mediated Inhibition
of RXR Function”, “LXR-RXR Activation”, “FXR-RXR Activation”, and “TR-RXR Activation”. Among the highest
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a

b

Fig. 10 The top panel (a) depicts another gene interaction network identified by IPA in the E18 vs. D3 contrast. This gene network, functionally
annotated by IPA as “Cell Signaling”, shows interactions of eight transcription factors (NFYC, THRSP, KAT2B, KLF13, EAF1, EAF2, SOX7 and SOX8) and
their direct target genes. The second gene network (b) was functionally annotated by IPA as “Hematological System Development and Function”.
This network of genes, which are highly expressed in liver of E18 embryos, involves interactions among six blood clotting factors [F5, F8, F9, F11,
PROS1 and von Willebrand factor (VWF)] with macrophage stimulating 1 (MST1), the chromatin remodeling gene [helicase lymphoid specific
(HELLS)], a mitochondrial chaperone [heat shock protein family D (Hsp60) member 1 (HSPD1)], SRY-box 7 (SOX7), several collagen genes (COL1A1,
COL3A1 and COL18A1), fibulin 1–2 (FBLN1, FIBLN2) and components of the extracellular matrix [secreted protein acidic and cysteine rich (SPARC),
laminin subunit beta-1, − 3 (LAMB1, LAMB3) and lysyl oxidase (LOX)]

AR-DEGs found in the liver of fasted D1 hatchlings were
IGFBP2, PDK4, PTGDS, PPARGC1A, CPT1A, LPL and
DIO3 (Table 7). In contrast, the fully-fed D9 hatchling
chicks showed higher expression of CDKN2B and several
lipogenic genes including SQLE, THRSPA, FADS2, SCD,
LSS and PNPLA3.

Two gene interaction networks from the D1 vs. D9
contrast were functionally annotated by IPA as involved in
“Lipid Metabolism” (Fig. 11). As shown in Fig. 11a, several
lipogenic transcription factors [SREBF2, THRSPA, MID1IP1
(a THRSP paralog), PLAGL, JUN and CREM] control expression of multiple metabolic enzymes (ACACA, HMGCR,
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Table 6 IPA summary of the liver transcriptome in the E20 vs. D3 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

Super-pathway of Cholesterol Biosynthesis

1.97E-09

69.6%

16/23

Cholesterol Biosynthesis I-III

1.82E-07

90.0%

9/10

Complement System

5.41E-07

58.3%

14/24

LXR/RXR Activation

7.87E-06

34.7%

25/72

Intrinsic Prothrombin Activation Pathway

2.00E-05

55%

12/20

Top Upstream Regulators

p-value of overlap

# Target genes

TP53

2.52E-23

257

PPARA

1.23E-20

100

E2F4

3.03E-20

71

E2F1

5.46E-18

105

FOXO3

6.20E-16

77

p-value

# Genes

Top Molecular and Cellular Functions
Cell Cycle

8.31E-04 - 5.90E-14

392

Cellular Assembly and Organization

8.35E-04 - 5.90E-14

188

DNA Replication, Recombination, and Repair

8.31E-04 - 5.90E-14

294

Lipid Metabolism

8.39E-04 - 1.88E-11

333

Small Molecule Biochemistry

8.39E-04 - 1.88E-11

382

p-value

# Genes

Physiological System Development and Function
Organismal Survival

2.88E-04 - 1.37E-05

470

Connective Tissue Development and Function

2.59E-04 - 1.65E-05

152

Tissue Morphology

2.88E-04 - 1.65E-05

219

Reproductive System Development and Function

8.08E-04 - 4.69E-05

10

Embryonic Development

5.07E-04 - 7.98E-05

35

Top Toxicity Functions

p-value

Overlap

Ratio

LXR/RXR Activation

1.04E-05

34.2%

25/73

Cholesterol Biosynthesis

4.67E-05

60.0%

9/15

Fatty Acid Metabolism

5.58E-05

33.3%

22/66

Cell Cycle: G2/M DNA Damage Checkpoint Regulation

6.76E-05

39.0%

16/41

FXR/RXR Activation

1.38E-04

30.4%

24/79

log2 Ratio

Top Down-regulated Genes

log2 Ratio

5.27

THRSPA

−9.13

Top Up-regulated Genes
MOGAT1
PDK4

5.04

CDO1

−6.73

ITGBL1

4.50

SQLE

−6.70

CPT1A

4.27

NSDHL

−6.62

PPM1K

4.16

FASN

−5.84

DNAJC12

3.91

SCD

−5.80

IGFBP2

3.68

ELOVL5

−5.51

CPED1

3.66

FADS2

−5.46

ZBTB16

3.37

CDKN2B

−5.01

MT3

3.36

CYP7A1

−4.98

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 1775 AR-DEGs identified in the E20 vs. D3 contrast (E20/D3 ratio). AR-DEGs
with positive log2 ratios are expressed higher in liver of E20 embryos, while negative log2 ratios indicate higher expression in D3 embryos
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Table 7 IPA summary of the liver transcriptome in the D1 vs. D9 contrast
Top Canonical Pathways

p-value

Overlap

Ratio

Superpathway of Cholesterol Biosynthesis

2.07E-08

73.9%

17/23

Cholesterol Biosynthesis I-III

3.03E-06

90.0%

9/10

Complement System

8.89E-06

41.7%

10/24

Stearate Biosynthesis

1.36E-05

36.7%

11/30

LXR/RXR Activation

1.42E-05

25%

18/72

Top Upstream Regulators

p-value of overlap

# Target genes

PPARA

4.31E-29

86

TP53

1.01E-24

179

E2F4

8.06E-18

51

SREBF2

8.28E-18

29

TCF3

9.21E-17

59

p-value

# Genes

Top Molecular and Cellular Functions
Cell Cycle

5.90E-04 - 5.96E-16

236

Cellular Assembly and Organization

6.09E-04 - 5.96E-16

103

DNA Replication, Recombination, and Repair

4.27E-04 - 5.96E-16

128

Lipid Metabolism

5.51E-04 - 1.94E-15

248

Small Molecule Biochemistry

5.51E-04 - 1.94E-15

281

p-value

# Genes

Connective Tissue Development and Function

5.90E-04 - 2.82E-07

129

Tissue Morphology

5.90E-04 - 2.82E-07

172

Physiological System Development and Function

Reproductive System Development and Function

5.51E-04 - 7.32E-07

16

Digestive System Development and Function

5.51E-04 - 1.50E-05

56

Hepatic System Development and Function

8.31E-05 - 1.50E-05

55

Top Toxicity Functions

p-value

Overlap

Ratio

Fatty Acid Metabolism

1.66E-07

30.3%

20/66

Cholesterol Biosynthesis

5.16E-07

60.0%

9/15

LXR/RXR Activation

1.74E-05

24.7%

18/73

Cell Cycle: G2/M DNA Damage Checkpoint Regulation

7.32E-05

29.3%

12/41

Liver Necrosis/Cell Death

1.07E-04

15.9%

35/220

log2 Ratio

Top Down-regulated Genes

log2 Ratio

3.79

CDKN2B

−8.46

Top Up-regulated Genes
CHODL
SRL

3.78

SQLE

−7.71

IGFBP2

3.05

THRSPA

−6.39

PDK4

2.95

FADS2

−6.19

PTGDS

2.89

SCD

−6.11

ACBD7

2.88

CDO1

−6.10

PPARGC1A

2.80

UCHL1

−5.86

CPT1A

2.77

LSS

−5.40

LPL

2.73

ENPEP

−5.17

DIO3

2.73

PNPLA3

−5.14

Ingenuity Pathway Analysis (IPA) was used for functional analysis of 1036 AR-DEGs identified in the D1 vs. D9 contrast (D1/D9 ratio). AR-DEGs
with positive log2 ratios are expressed higher in liver of D1 embryos, while negative log2 ratios indicate higher expression in D9 embryos
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Fig. 11 The D1 vs. D9 contrast revealed two distinct gene networks centered on interaction among multiple lipogenic transcription factors. The
gene network shown in Panel a was functionally annotated as “Lipid Metabolism”. Seven upstream regulators [THRSP, MID1 interacting protein 1
(MID1IP1 or THRSPL), SREBF2, cAMP responsive element modulator (CREM), Jun proto-oncogene, AP-1 transcription factor subunit (JUN), BTG antiproliferation factor 2 (BTG2) and PLAG1 like zinc finger 1 (PLAGL1] and their direct target genes were mainly expressed at higher levels in liver of
fed D9 hatchlings. The gene network in Panel b focusses on interactions of PPARG, which was expressed higher in liver of fully-fed D9 hatchlings,
with four other transcription factors, three of which (NCOR1, NR0B1 and PPARGC1A) were more abundant in liver of fasted D1 hatchling chicks

FDPS, SQLE, AACS, LSS, CYP8B1, IDI1, MVD, COMT,
FBXL12 and ACAT2), kinases (MASTL, SIK1), a phosphatase (LPIN1), and transporters (STARD4 and SLC6A6). The
gene network in Fig. 11b shows interactions of five transcription factors (PPARG, PPARGC1A, NR0B1, NCOR1and
ZBTB20) with key lipogenic metabolic enzymes (FASN,
ME1, CPT1A), growth factors (IGF1), binding proteins

(IGFBP1, IGFBP2, IGFALS) and the adiponectin receptor
(ADIPOR2). Other direct targets of PPARG shown in this
gene network were NDRG1, PLIN2, PER3 and VNN1.
The final gene interaction network (Fig. 12a) was also
identified in the D1 vs. D9 contrast and functionally annotated by IPA as belonging to “Energy Production”
and “Lipid Metabolism”. This network is centered on
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Fig. 12 This gene network from the D1 vs. D9 contrast was functionally annotated by IPA as “Energy Production, Lipid Metabolism”. Panel a
shows interactions among several lipogenic transcription factors [THRSPA, PPARG, PPARD and Kruppel like factor 15 (KLF15)] and their direct target
genes, which are mainly expressed at greater levels in liver of D9 hatchlings. However, four target genes of KLF15, itself upregulated, were upregulated in the liver of D1 hatchlings [i.e., hydroxyacyl-CoA dehydrogenase trifunctional multi-enzyme complex subunit alpha (HADHA), HADHB,
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase (EHHADH) and pyruvate dehydrogenase kinase 4 (PDK4)]. Panel b shows known
direct targets of PPARD and KLF15 and Ingenuity predictions of inhibition (blue arrows) or activation (dark orange arrows) of both the up-stream
regulator and its respective gene targets. Ingenuity predicts inhibition of PPARD, due to the majority of downregulated target genes in the D1 vs.
D contrast, which would lead to inhibition of 12 genes (blue arrows), whereas the blunt orange lines predict that PPARD actively inhibits cyclin
dependent kinase 1 (CDK1), carnitine palmitoyltransferase 1A (CPT1A) and lipoprotein lipase (LPL), which are highly expressed in liver of fasted D1
hatchlings. Ingenuity predicts that activation of KLF15 in fasted D1 hatchlings would lead to activation of seven known target genes [solute
carrier family 27 member 1 (SLC27A1), acyl-CoA synthetase long chain family member 1 (ACSL1), EHHADH, FABP5, HADHA, HADHB and PDK4],
although uncertainty exists about KLF15’s action on five other AR-DEGs as indicated by the blunt yellow edges

interactions among four lipogenic TFs (THRSPA,
PPARG, PPARD and KLF15), where PPARG and PPARD
share seven target genes (PER3, DUT, CPT1A, THRSPA,
LPIN1, ACOX2 and PDK4). The TF PPARG and several

of its direct targets are expressed at higher levels in liver
of D9 hatchlings, including ADIPOR2, FBXO9, ELOVL6,
ELOVL2, ELOVL1, HSD17B12, PEX11A, HECTD2, VNN1
and FDPS. The fasting-induced transcriptional factor
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KLF15 and four direct gene targets (HADHA, HADHB,
EHHADH and PDK4) are expressed higher in liver of
fasted D1 hatchlings. The Ingenuity Upstream Regulator
Analysis (Fig. 12b) identified 30 AR-DEGs in the D1 vs.
D9 contrast as direct targets of PPARG, where only 9
genes were up-regulated in the fasted D1 hatchlings. Consequentially, IPA predicted that PPARG would be inhibited (blue gene symbol and blue arrows), since 21 of its
target genes are down-regulated (green symbols) ARDEGs in this contrast. Based on known relationships in
the Ingenuity Knowledge Base, Ingenuity predicts that
inhibited PPARG would block the expected activation
(blunt orange lines) of CDK1, CPT1A and LPL. Ingenuity
predicts that KLF15 would be activated, which would lead
to activation (up-regulation) of seven direct targets
(ACSL1, EHHADH, FABP5, HADHA, HADHB and PDK4)
as indicated by the orange arrows. Interestingly, KLF15, a
key transcriptional regulator of gluconeogenesis, was
highly expressed in liver of fasted D1 hatchling chicks, as
revealed by three pairwise contrasts (E18 vs. D1; D1 vs.
D3; and D1 vs. D9).
qRT-PCR analysis and verification of differential
expression of 15 candidate DEGs

Hepatic expression patterns of seven DEGs that were
expressed higher in embryos and an invariant gene
(COX7A2L) during the embryo-to-hatchling transition
were examined by qRT-PCR analysis (Fig. 13). Six genes
(MOGAT1, PDK4, FZD2, LDHB, DIO3 and ADIPOQ)
show higher log-based expression in embryos and a
sharp decline after hatching. Surprisingly, hepatic expression of DIO1 was relatively stable, except in E18
embryos where DIO1 was slightly elevated. The invariant
gene (COX7A2L) was used by geNorm software for normalization of the qRT-PCR expression levels. The expression patterns of eight lipogenic genes during the
embryo-to-hatching transition are depicted in Fig. 14.
The hepatic expression of THRSPA and SCD was logscale and increased exponentially, reaching a plateau in
liver of fed hatchlings between D3 and D9. Similar
log-scale expression patterns were found for fiv other
metabolic genes (ME1, SCD, FASN, ATPCL and ELOVL6),
while HMGCL and HMGCS2 only showed a slight increase in transcript abundance in D9 hatchlings.
Figure 15 provides a side-by-side comparison of genome
array analysis vs. qRT-PCR analysis for 13 “candidate”
genes across 6 developmental ages (E16-D9). In general,
transcript abundance determined by genome array analysis was of a lower magnitude than the dynamic log-scale
range provided by qRT-PCR analysis, although patterns of
gene expression were similar between thetwo analytical
methods. Three lipolytic DEGs identified by genome array
analysis (Fig. 15a, top) exhibited higher expression in liver
of embryos than in hatchings [i.e., DIO3, MOGAT1 and
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pyruvate dehydrogenase kinase 4 (PDK4)]. The deactivating deiodinase DIO2 and the adipokine ADIPOQ showed
a progressive increase in hepatic expression from E16 to a
peak in E20 embryos. Although DIO2 levels were lower in
D1 and D3 hatchlings, a peak in abundance was reached
in D9 hatchlings. The qRT-PCR analysis (Fig. 15a, bottom)
revealed high magnitude (log2) expression of DIO3,
MOGAT1 and PDK4, which were highest in E16 and E18
embryos and lowest in liver of fully-fed D3 and D9 hatchlings. Likewise, the hepatic abundance of ADIPOQ, FZD2
and LDHB transcripts were also elevated in embryos compared to hatchlings, albeit with lower amplitudes. Seven
DEGs identified by genome array analysis (Fig. 15b, top)
displayed relatively low expression in liver of embryos
with a sharp rise in expression in fully-fed D3 and D9
hatchlings. The developmental pattern and large-amplitude expression of THRSPA, ME1 and ELOVL6 transcripts were almost identical and reached a plateau in
liver of fed D3 and D9 hatchlings. HMGCL levels were
similar across embryonic ages and only slightly greater
in D3 and D9 chicks. Also, the abundance of SCD was
low in embryos and fasted D1 hatchlings, with a sharp
increase in fed D3 and D9 hatchlings. In contrast,
qRT-PCR analysis (Fig. 15b, bottom panel) shows an
extremely high abundance of THRSPA and SCD in liver
of D3 and D9 hatchlings that was several orders of
magnitude greater than in liver of embryos (E16-E20).
Five hepatic genes (FASN, ME1, ATPCL, ELOVL6 and
HMGCL) had higher expression levels, albeit with a
lower amplitude, in D3 and D9 hatchlings. We were
surprised to find that hepatic expression of DIO1 was
rather stable across embryonic (E16-E20) and hatchling
(D1-D9) ages. Furthermore, DIO1 was not detected as a
DEG by genome array analysis or qRT-PCR analysis;
therefore, DIO1 was considered an invariant gene and
not included in the Pearson’s Correlation Analysis.
The Pearson’s correlation coefficient (r = 0.929; 11 degrees of freedom) indicates a highly significant (P ≤ 0.01)
correlation between gene expression levels obtained
from both microarray and qRT-PCR analyses (Additional
file 8). As expected, there was close agreement in hepatic
transcript abundance between expression platforms
(microarray and qRT-PCR analyses); the major difference was the large-magnitude log-scale expression levels
achieved by qRT-PCR analysis, albeit the developmental
expression patterns were quite similar.

Discussion
The present study of liver during the embryo-to-hatchling
transition (or peri-hatch period) provides a detailed view
of the innate choreography of major transcriptional responses involved in the abrupt switch from a lipid-laden
ectotherm (embryo) to a free-living endotherm (hatchling
chick). We have identified several transcription factors
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Fig. 13 This figure depicts the qRT-PCR analysis of seven “lipogenic” DEGs identified by genome array analysis. Each value represents the mean ± SEM
of four biological samples (individual embryo or hatchling liver) and their two technical replicates in the qRT-PCR analysis. Values possessing different
superscripts are significantly different as determined by ANOVA and mean separation using Duncan’s Multiple Range Test in SAS. These genes
are mainly involved in lipolysis and energy catabolism; and all are expressed at higher levels in embryos, with the exception of the invariant
gene cytochrome c oxidase subunit 7A2 like (COX7A2L). The invariant gene was one of three housekeeping genes used for normalization of
transcript abundance in liver of embryos and hatchling chicks. Gene symbols: Monoacylglycerol O-acyltransferase 1(MOGAT1); pyruvate dehydrogenase
kinase 4 (PDK4); frizzled class receptor 2 (FZD2); lactate dehydrogenase B (LDHB); iodothyronine deiodinase 3 (DIO3); iodothyronine deiodinase 1 (DIO);
and adiponectin, C1Q and collagen domain containing (ADIPOQ)

(PPARA, PPARGC1A, KLF15, SIRT1, SERTAD2 and
NR1H4) which interact with each other and their respective target genes in late embryos as they utilize yolk
lipids and prepare for hatching on E21. Upon feeding,
hatchling chicks abruptly increase expression of several
ligand-activated transcription factors (THRSPA, SREBF2,
PPARG, PPARD and KLF11) which in turn control

numerous down-stream metabolic enzymes, transporters
and kinases/phosphatases to support greater rates of energy expenditure for lipogenesis, adipogenesis and somatic
growth. Hierarchical clustering revealed two opposing patterns of gene expression in liver during the peri-hatch
period, where Cluster A had higher expression in embryos, which sharply declined after hatching (see Fig. 1).
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Fig. 14 This figure shows the qRT-PCR analysis of eight “lipogenic” genes, which were originally identified as DEGs by genome array analysis.
These genes were more abundant in liver of hatchlings. Each value represents the mean ± SEM of four biological samples (individual embryo or
hatchling liver) and their two technical replicates. Values possessing different superscripts across ages were significantly different as determined
by ANOVA and mean separation using Duncan’s Multiple Range Test in Statistical Analysis System (SAS)Gene symbols: Thyroid hormone-responsive Spot
14 protein, alpha (THRSPA); delta-9 desaturase (SCD); fatty acid synthase (FASN); malic enzyme 1, NADP(+)-dependent, cytosolic (ME1); ATP citrate lyase
(ATPCL); ELOVL fatty acid elongase 6 (ELOVL6); 3-hydroxy-3-methylglutaryl-CoA lyase (HMGCL); and 3-hydroxy-3-methylglutaryl-CoA synthase (HMGCS2)

In contrast, Cluster B genes exhibited lower expression in
embryos, which was followed by an exponential increase
in abundance of numerous lipogenic genes in fully-fed D3
and D9 hatchlings. These two distinct patterns represent
clusters of functionally-related genes that are similar to
those found in our original transcriptional profiling of
liver in embryos and hatchlings during the peri-hatch
period using a prototype 3.2 K chicken liver microarray

[19, 30, 31]. Self-organizing maps (SOMs) analysis of the
first transcriptional scans using our 3.2 K liver cDNA
array (NCBI GEO Platform No. GPL1742) revealed similar distinct patterns of transcript abundance. Cluster 11
contained 46 genes with higher expression in embryos,
whereas Cluster 3 (21 genes) had lower expression in embryos with a sharp elevation in hatchlings [19]. Higher
resolution of functionally related gene clusters, unique to
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Fig. 15 This figure provides the side-by-side comparison of gene expression levels determined by genome microarray analysis and their verification by
qRT-PCR analyses for 15 candidate DEGs. This four panel figure provides visual contrasts of lipolytic (Panel a) and lipogenic (Panel b) genes and their
differential expression determined by two independent analyses of 24 biological samples (12 embryos and 12 hatchlings). In Panel a, the normalized
expression levels of five lipolytic DEGs from genome array analysis and time-course verification by qRT-PCR analysis are displayed in respective order,
with genome array data in the top panel and its verification by qRT-PCR analysis in the bottom panel. Panel b shows hepatic expression patterns of
seven lipogenic genes (THRSPA, SCD, ME1, FASN, ELOVL6, ACLY and HMGCL) as determined by genome array (top) and by qRT-PCR (bottom) analyses.
Log scale expression levels were achieved by qRT-PCR analysis as shown in both bottom panels. Relative expression levels obtained by these two
independent methods were used for Pearson’s correlation analysis and the determination of the Pearson’s correlation coefficient (see Additional file 8).
Note: DIO1 was considered an invariant gene; therefore, DIO1 expression was not included in the Pearson’s Correlation Analysis

embryos and to hatchling chicks, was achieved with our
spanning-tree clustering method (see Fig. 3 in [31]). Our
original transcriptional profiling analysis with a low
density 3.2 K microarray provided us with a coarse view
of the topography of hepatic gene expression during
the embryo-to-hatchling transition. The present transcriptional analysis using chicken genome arrays has
greatly expanded the repertoire of responsive hepatic
genes involved in the embryo-to-hatchling transition
and considerable insight into the regulatory and metabolic pathways that control the abrupt switch from embryonic ectotherm to hatchling endotherm.
Transcriptional regulation of metabolism during the
peri-hatch period

The present study utilized multiple pairwise contrasts
between embryos and hatchlings to gain even greater
resolution by populating canonical pathways and biological processes with DEGs, which provide homeorhetic
control over metabolism during the peri-hatch period.
The primary contrast of all embryos against all hatchlings

revealed a large number of hepatic DEGs (284 genes) that
are involved in lipid metabolism (Table 1). And of these,
149 DEGs belong to the lipid synthesis pathway, where
only one-third (54) of the DEGs are more abundant in
liver of embryos. We discovered 14 up-stream regulators
that control transcription of a large number of metabolic
enzymes, transporters, phosphatases and kinases in liver
of embryos and hatchlings (see Fig. 4). Membrane-bound
and nuclear ligand-activated receptors and G-protein
coupled receptors (GCPRs) fine tune and amplify the signals mediated by a few critical transcription factors. These
enhanced metabolic activities are enabled by a robust thyroid axis and deiodinases with opposing actions. In the
embryo liver, DIO3 converts the prohormone T4 into
inactive rT3 until the moment the embryo pips through
its shell and begins pulmonary respiration [16]. Furthermore, the abrupt rise in regulated body temperature
(Tb = 42–44 °C) of precocial hatchling chicks is supported
by increased hepatic DIO2 activity, which converts T4 into
metabolic T3, the major hormone of thermoregulation
and energy expenditure. DIO3 was one of the highest
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DEGs in liver of embryos, whereas DIO2 was the
highly-expressed and opposing deiodinase found in liver
of hatchlings by multiple contrasts. Initially, DIO1 was
considered to be the major hepatic deiodinase providing
active thyroid hormone (T3) for rapid growth and metabolism in hatchling chicks [15, 18]. The present study
clearly shows that DIO2 expression increases in E20 liver
to provide metabolically-active thyroid hormone (T3) for
hatching and reaches maximum expression in fully-fed
rapidly-growing D9 chicks. The importance of DIO3 in
deactivating T4 was demonstrated by the D1 vs. D9 contrast, where DIO3 was highly expressed in liver of fasted
D1 hatchlings and sharply depressed in fed D3 and D9
hatchings. The opposing actions of DIO3 and DIO2 on
lipid catabolism or lipogenesis (respectively) were evident
across multiple contrasts of embryo and hatchling liver
(see Additional file 3).
As expected from our previous transcriptional scans
[19, 30–35], major lipogenic transcriptional factors
(THRSPA, SREBP2, PPARG, PPARD and KLF11) interact
with each other to control numerous target genes encoding metabolic enzymes, transporters and kinases/
phosphatases that support lipogenesis and the thermogenic drive, which sharply increases after hatching and
consuming high-energy high-protein feed. Of particular
interest, was the over-representation of AR-DEGs (27
genes) observed in the “THR-RXR Activation” pathway
(see Additional file 4), where the most abundant DEGs
expressed in embryo liver was DIO3, which deactivates
both prohormone (T4) and metabolically-active (T3) thyroid hormone, whereas DIO2 activates the thyroid axis
by converting T4 to T3, the active thyroid hormone and
major regulator of energy metabolism and lipogenesis.
Furthermore, T3 bound to its ligand-activated receptor
(THRB) sequentially activates triple T3-THRB binding
sites on the THRSP promoter to provoke an exponential
increase in transcription of the THRSP gene [36]. In the
present study, THRSPA followed a distinct sigmoidal
expression pattern during the embryo-to-hatchling
transition (see Fig. 15b), as demonstrated by qRT-PCR
analysis. The increased generation of T3 by DIO2 in
liver of hatchlings provides ligand for binding to and
activating the THRB, an essential step in the progressive activation of THRSPA. Furthermore, activated nuclear receptor (T3-THRB) also serves as a binding
partner (heterodimer) for several other nuclear receptors (FXR, LXR, RXR and VDR). For example, the
THRSP promoter in the rat has three T3-THR response
elements which act synergistically to provide maximal
transcription of the THRSP gene [36]. Transcription of
THRSP is regulated by several other ligand-activated
nuclear receptors: SREBP1c via sterol response elements (SRE) [37], retinoic acid-RXR [38], NR1I3, pregnane X receptor (PXR), CAR-RXR complex [39],
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estrogen via estrogen response elements (ERE) [40], and
several metabolites: [glucose bound to carbohydrate regulatory element binding protein (ChREBP) [41], polyunsaturated fatty acid [42] and prostaglandin [43]. In the
present study, we identified a lipogenic gene network in
the D1 vs. D9 contrast (see Fig. 11a) where THRSP and its
paralog MID1 interacting protein 1 (MID1IP1) [also
known as THRSPL/S14R] were up-regulated in liver of D9
hatchlings with direct interactions with SREBF2 and
ACACA, which encodes the rate limiting enzyme in fatty
acid synthesis. Apparently, both THRSP and MID1IP1 are
glucose-responsive genes, which have overlapping roles in
regulating expression of several lipogenic genes [44].
These observations strongly support activation of the thyroid axis in hatchlings to increase energy expenditure to
meet demands of endothermy and rapid somatic growth.
The present study affirms and extends our original idea
that THRSPA controls transcription of several metabolic
enzymes and transporters, which contribute to lipogenesis
and the exponential growth exhibited by newly-hatched
(meat-type) chicks. Previously, we have shown abundant
expression of THRSPA in abdominal fat and liver of the
chicken and demonstrated its involvement in adipogenesis
and lipogenesis [19, 30, 31, 33, 34, 45, 46]. Furthermore,
we discovered a 9 bp insertion/deletion polymorphism in
the DNA binding domain, which is associated with the abdominal fatness trait in multiple populations of broiler
chickens. Others have shown that mutations in the
THRSPA gene are associated with fatness phenotypes in
chickens [47, 48], ducks [49] and geese [50]. Taken together, THRSPA is obviously a major regulatory of lipogenic genes expressed in liver and visceral fat of the
chicken and other poultry, like ducks and geese. A recent
study in mice provides direct evidence that enhanced
THRSP expression is controlled via a LXR-mediated,
SREBP-dependent mechanism [51]. These extensive findings strongly support the full recognition of THRSPA as a
principal transcriptional regulator of lipogenesis and adipogenesis in the chicken and other domestic birds.
The transcriptional choreography of the metabolic
switch from embryo to hatchling includes interaction of
several ligand-activated nuclear receptors [52] namely,
farnesoid X receptor (FXR or NR1H4; activated by bile
acids and cholesterol derivatives), liver X receptor (LXR;
activated by oxysterols and other cholesterol derivatives), the orphan nuclear receptor small heterodimer
partner (SHP or NROB2), which regulates metabolism
of cholesterol, bile acids, fatty acids and glucose [53],
and PPARA. The overlapping roles and interplay of the
ligand-activated nuclear receptors LXR and RXR has
been elegantly described as a “ying and yang relationship”, which precisely regulates bile acid, cholesterol
and triglyceride metabolism [52]. Presently, most pairwise
contrasts of embryo and hatchling liver transcriptomes
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have identified activation of LXR-RXR, and FXR-RXR
heterodimers as over-represented metabolic pathways.
Furthermore, we discovered other examples of opposing
(or ying-yang) transcriptional regulators (i.e., PPARA vs.
PPARG; SIRT1 vs. PPARG; SIRT1 vs. SREBF2; PPARG vs.
PPARGC1A; SREBF2 vs. PPARA; NR0B2 vs. NR1H4;
THRSPA vs. PPARA, and THRSPA vs. PPARGC1A) and
metabolic enzymes (i.e., DIO3 vs. DIO2). Furthermore, we
identified 9 of the 15 known members of the Kruppel-like
transcription factor (KLF) family [54] as DEGs (KLF2,
KLF3, KLF6, KLF9, KLF10, KLF11, KLF12, KLF13 and
KLF15) from our 14 pairwise contrasts (Additional file 3).
In particular, KLF15 seems to act as a homeorhetic transcription factor capable of “switching between lipogenesis
and gluconeogenesis during fasting” [55]. This dynamic
adaptation in energy metabolism is achieved by KLF15
forming complexes with LXR-RXR heterodimers on the
promoter of mouse SREBF1c, thereby inhibiting transcription of this major lipogenic transcription factor.
The ability of KLFs to either activate or repress gene
transcription depending upon metabolic demands was
recently reviewed in an article that precisely coined
their dynamic action as “crippling and uncrippling metabolic pathways” [54]. The present examination of liver
transcriptomes clearly shows interactions, interdependence and interconnectivity of multiple upstream regulators and their direct target genes in regulating lipolysis in
late embryos and lipogenesis in fully-fed D3 and D9
hatchling chicks.
The NAD+-dependent deacetylase SIRT1 is involved
in alternative energy utilization, like β-oxidation of
lipid and gluconeogenesis [56–58], which are critical
metabolic processes in liver of late embryos. Furthermore, SIRT1 enhances thyroid (T3) control over expression of several lipogenic genes, including CPT1A,
PPARA, PPARGC1A, PDK4, PCK1 and SREBP-1c [59].
Another transcription factor up-regulated in liver of
embryos was prospero-related homeobox 1 (PROX1),
which is important for hepatic embryogenesis and a
negative regulator of triglyceride synthesis via mTOR
signaling [60]. Thus, the metabolism of the late
chicken embryo is under the intricate control of multiple transcription factors and directed at utilization of
yolk lipids that amass in liver. The retained yolk sac
provides nutrients and lipid-derived energy until the
hatchling eats its first meal and becomes a selfsufficient endotherm. In the present study, we included
D1 hatchlings, which had not been fed and still
dependent on yolk-lipid and swallowed albumen to
reach and maintain endothermy. Full and untethered
expression of multiple transcription factors and their
target genes that contribute to lipogenesis occurs only
after the hatchling chick is fully-fed (D3 and D9) and
the residual yolk sac depleted.
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Another interesting TF identified in the four contrasts
of embryos and hatchlings was SERTA domain containing 2 (SERTAD2; also known as TRIP-Br2), which was
expressed at highest levels (log2 ratio = + 1.75) in the
E16 vs. D1 contrast. The differential expression of SERTAD2 was found in three additional contrasts of embryos against hatchlings (E vs. H, E16 vs. D3 and E18 vs.
D1). This newly-discovered transcriptional co-regulator
is highly expressed in visceral fat of obese humans; furthermore, SERTAD2 appears to control lipolysis, oxidative metabolism and thermogenesis in mouse models
[61–63]. Knockout of the SERTAD2 gene in mice prevents diet-induced obesity, insulin resistance and inflammatory responses in visceral fat. Our discovery of
up-regulated SERTAD2 in liver of E16 and E18 chick
embryos suggest that this transcriptional co-regulator
could contribute to transcriptional control of lipolysis
and oxidative metabolism in the lipid-laden liver of late
chick embryos via interactions with known lipolytic TFs
(i.e., PPARA, PPARGC1A, SIRT1 and NR1H4).
Our present transcriptional study has also revealed acquisition of a competent blood clotting system in E16
and E18 embryos, which exhibit abundant differential
expression of multiple coagulation factors and collagen
genes (see Figs. 6a and 10b; Additional files 4 and 6).
The deacetylase SIRT1 appears to control essential biological pathways like blood coagulation through selective
acetylation of clotting factors and the closely related
acute-phase response proteins [57]. SIRT1 also enhances
PPARA-PPARGC1A driven lipolysis and lipid depletion
of adipocytes, which in turn activates gluconeogenesis a
vital metabolic response of the embryo. The largest
number of coagulation genes was found in the E18 vs.
D3 contrast, where 10 clotting factors and 7 collagen
genes were expressed higher in the E18 embryo. Similarly, 12 blood clotting factors were found in the E20 vs.
D3 contrast, where 9 coagulation and 3 collagen genes
were up-regulated in the liver of E20 embryos. In
addition, fibrinogen alpha (FGA) was over-expressed in
E18 and E20 embryos (see Additional file 3). The transcriptional analysis of the chicken yolk sac in late
chicken embryos (E13-E21) revealed peak abundance of
fibrinogen (β and γ subunits; FGB and FGG) genes at
E19 [8]. Presumably, a competent blood coagulation system is crucial to prevent excessive blood loss in the embryo during absorption of its residual yolk sac into the
visceral cavity, destruction of the chorioallantois, and
emergence of the E21 embryo as a hatchling chick [64].
Hepatic expression of the feather keratin gene FKER

Interestingly, FKER was the most DEG found in liver of
E16 embryos (see Additional file 3). In fact, seven distinct transcripts represented on the Affymetrix Chicken
Genome Array correspond to feather keratin or feather
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keratin-like genes (Table 8), which reside at multiple loci
on the chicken genome (GGA1, GGA25 and GGA27)
[65–67]. Five of these over-expressed FKER transcripts
map to GGA25, while FK1 (BI064513) resides on GGA1
and XM_424568 is located on GGA27. At first glance,
abundant expression of FKER in liver of the E16 embryo
seems difficult to explain. However, we originally discovered the exceptional, and very high, abundance of FKER
in liver of E15 embryos from Leghorn (egg-type) chickens carrying the riboflavin binding-protein deficiency
mutation rd/rd, with or without riboflavin rescue [35].
We proposed that the abundant hepatic expression of
FKER exclusively in E15 embryos could be related to
massive engorgement of the embryo’s liver with yolk
lipids, which normally occurs at this stage of embryonic
development. In fact, an early study described the presence of lipids in the embryo’s developing cutaneous feather, which was likely associated with “pre-keratin”,
where lipids function as the scaffold for feather keratin
formation [68]. In the mouse, cytoskeletal keratin 8
(Krt8) is required for structure and integrity of hepatocytes [69]. Furthermore, ablation of the Krt8 in mice results in oxidative stress and excessive accumulation of
lipid and protein metabolites [70]. Examination of the
pigeon’s lactating crop transcriptome has revealed upregulation of several β-keratin genes, including FKER,
which are ultimately involved in production of lipidladen crop milk [71]. The unique synthesis of crop milk
in Columbiformes involves prolactin-mediated cornification and lipid synthesis of crop epithelial cells, which are
desquamated and sloughed off to form “crop milk”,
which is fed to the altricial squabs. This transcriptional
study of pigeon crop milk production clearly shows
over-expression of multiple β-keratin genes, which are
associated with de novo lipid synthesis and cornification of crop epithelium. Of particular interest, all of
the differentially-expressed lipogenic genes found in
the lactating pigeon crop sac were identified as DEGs
in the present study, including the highly-expressed

lipogenic transcription factor THRSPA [71]. The
present descriptive study of the liver transcriptome
during the embryo-to-hatchling transition validates
our original discovery of abrupt over-expression of
FKER in E15 Leghorn (egg-type) embryos [35], which
coincides with massive accumulation of yolk lipid in
liver that fuels the final embryonic growth phase and
emergence of the hatchling chick. Additional support
for the ectopic expression of hepatic FKER transcripts
in E16 Leghorn embryos is provided by our initial observation of differential expression of a cDNA target
(pgf1n.pk001.j5; GenBank BI064513) on a low-density
3.2 K chicken microarray (NCBI GEO Platform GPL1742)
[19]. This cDNA clone (pgf1n.pk001.j5) was sequenced
from a normalized adipose cDNA library derived from
embryo and hatchling chickens. Furthermore, our recent
transcriptional study of liver from rd/rd Leghorn embryos,
riboflavin-deficient and riboflavin rescued, utilized the
Arizona 20.7 K chicken oligo array (NCBI GEO Platform
GPL6049), where three 70-mer oligo targets [Roslin Institute Gallus gallus (RIGG) oligo; RIGG10897, RIGG14163
and RIGG14953] had 19-times greater abundance in liver
of riboflavin-rescued embryos than riboflavin-deficient
embryos between E13 and E15. Thus, three independent
chicken microarray platforms and multiple expressedsequence tag (EST) sequences in GenBank clearly support
abundant “ectopic” expression of FKER in liver of E15 and
E16 embryos from both egg-type (Leghorn) [35] and, presently, meat-type (broiler) chicken breeds. However, the
biological function of FKER in the lipid-laden liver of late
embryos and the relationship between hepatic expression
and cutaneous expression of FKER in embryos will require
further definitive study.

Conclusions
The present analysis of the embryo-to-hatchling transition
in meat-type chickens provides the first detailed view of
the choreography of innate and dynamic transcriptional
responses made by embryos and newly hatched chicks

Table 8 Multiple Affymetrix FKER probe sets (transcripts) highly expressed in liver of E16 embryos
Affymetrix ID

SYMBOL

GENE NAME

Log2 FC

GGA

ACC. NUM.

Gga.8960.3.S1_at

FKER

feather keratin 1-like

3.91

25

BX270499

REFSEQ ID
NM_001277801

Gga.6482.1.S1_at

LOC431324

keratin A

3.43

25

BX262674

NM_001101732

Gga.8960.2.S1_at

FKER

feather keratin 1

3.18

25

AAA48930

NM_001081702

Gga.6264.1.S1_at

FKER

feather keratin 1

2.76

1

BI064513

NM_001277751

Gga.8960.1.S1_at

FKER

feather keratin 1-like

2.37

25

BX950836

NM_001277929

Gga.6558.1.S1_at

FKER

feather keratin 1-like

2.28

25

NM_001277960

NM_001277960

Gga.7285.1.S1_at

FKER

feather keratin 2-like

1.89

27

XM_424568

XM_424568

Six of these FKER transcripts were the highest DEGs found in liver of E16 vs. E18 embryos. GenBank Accession number BI064513 is our chicken abdominal fat
cDNA clone pgf1n.pk001.j5, which was sequenced from a normalized chicken abdominal fat cDNA library
Abbreviations: feather keratin (FKER), fold-change (FC), Gallus gallus (GGA) chromosome, GenBank accession number (ACC. NUM.)
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during the critical metabolic jump from lipid-laden ectotherm to free-living self-sufficient endotherm, respectively.
The metabolism of late (E16-E20) embryos is dominated
by β-oxidation of yolk lipids, glycolysis and gluconeogenesis, which utilizes the residual albumen and other proteins
in allantoic fluid ingested by the embryo just prior to
hatching. These metabolic processes are precisely controlled by multiple and interacting transcription factors
(PPARA, PPARGC1A, NR1H4 and SIRT1, SERTAD2,
KLF11, KLF13 and KLF15) and scores of metabolic enzymes, transporters, phosphatases and kinases. The metabolites derived from these processes interact with
nuclear receptors, G-coupled protein receptors (GCPRs),
transmembrane receptors and extracellular factors. Highly-expressed hepatic DIO3 inactivates thyroid hormones
in the embryo, while its expression sharply declines in
hatchling chicks. Although hepatic expression of DIO1
was rather constant during the peri-hatch period, another thyroid hormone-activating enzyme DIO2
reached peak abundance at two ages, E20 and D9.
Upon pipping through the egg shell, the hatching chick
immediately converts to the pro-hormone T4 into
metabolically-active T3, which supports achievement of
thermodynamic freedom in hatchlings and synergetic
activation of THRSPA, the major lipogenic transcription factor in chickens. Furthermore, T3 bound to its
receptor (THRB) forms heterodimers with other nuclear receptors, which then control programmed expression of major lipogenic enzymes (FASN, ME1, SCD,
ELOV2, ELOV25, ELOV26, LSS, AGPAT2, ACACA,
CYP7A, DHCR7 and DHCR724). In addition to THRSPA,
other transcriptional regulators (PPARG, PPARD, LPIN1,
KLF11 and SREBF2) also interact and contribute to the
sharp increase in lipogenesis observed in liver of D3 and
D9 hatchlings.
Our present observation of the extraordinary expression of multiple FKER transcripts in liver of E16 embryos from meat-type chickens validates our original
discovery of highly-expressed FKER gene in liver of e15
Leghorn (egg-type) chickens. We have proposed that
hepatic expression of FKER in e15-e16 embryos could
be an adaptive response to the coincident and massive
accumulation of yolk lipids. This idea is supported by
the exceptional expression of multiple β-keratin transcripts, including FKER, in the lactating crop sac of the
pigeon [71], which accumulates and synthesizes lipids in
production of “crop milk” that nourishes the altricial
squabs. Many of the DEGs involved in de novo synthesis
of triglycerides in the pigeon’s lactating crop sac are also
found in liver of hatchling chicks, including the major
lipogenic transcription factor THRSPA. Nevertheless,
the biological function of FKER expressed in liver of
e15-e16 embryos and the relationship between hepatic
FKER and cutaneous FKER remain to be elucidated by
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definitive study. The present study provides new insight
into dynamic interaction of multiple transcription factors and their direct target genes that provide homeorhetric regulation of metabolism during the abrupt
embryo-to-hatchling transition of the domestic chicken,
Gallus gallus.
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Additional file 1: Experimental design of microarray hybridizations. A
Microsoft Excel file containing a single work sheet “Array Hybridization
Design” which describes the hybridization scheme used for the 24
Affymetrix Chicken Genome Arrays. (XLSX 12 kb)
Additional file 2: Primers used for qRT-PCR analysis. A Microsoft Excel
file containing a single work sheet “qRT-PCR Primer Information”. This table
provides the chicken gene symbol, GenBank ID number, 5′-3′ sequence for
forward and reverse primers, and amplicon size (bp) for each gene used for
qRT-PCR analysis. (XLSX 12 kb)
Additional file 3: Annotated gene list for 14 pairwise contrasts of liver
transcriptomes in embryos and hatchlings across six ages during the
peri-hatch period (E16-D9). The last worksheet provides the list of 1005
commonly-shared AR-DEGs identified by the Venn diagram shown in
Fig. 3b. Each worksheet provides a list of the “Analysis Ready” (AR)-DEGs
(FDR adjusted P ≤ 0.05; ±0.75 cutoff) for each contrast. (XLSX 905 kb)
Additional file 4: Canonical and biological pathways identified by the
contrast of all embryos vs. all hatchlings. The AR-DEGs from the E vs. H
contrast were assigned by Ingenuity Pathway Analysis (IPA) to canonical
and functional and pathways. Fisher’s Exact Test is used in IPA to determine
probability (P ≤ 0.05) that AR-DEGs belong to a particular canonical pathway
or biological function accrued in the Ingenuity Knowledge Base. (XLSX 53 kb)
Additional file 5: Canonical and biological pathways identified by IPA in the
E18 vs. E20 contrast. The AR-DEGs from the E18 vs. E20 contrast were assigned
by IPA to overrepresented canonical and functional pathways. IPA uses Fisher’s
Exact Test to determine probability (P ≤ 0.05) of each AR-DEG belonging to a
particular canonical pathway or biological function. (XLSX 36 kb)
Additional file 6: Canonical-biological pathways identified by IPA in the
contrast of E18 embryos vs. D3 hatchlings. The AR-DEGs identified in the
E18 vs. D3 contrast were assigned by IPA to overrepresented canonical
and functional and pathways. IPA uses Fisher’s Exact Test to determine
probability (P ≤ 0.05) of each AR-DEG belonging to a particular canonical
pathway or biological function. (XLSX 44 kb)
Additional file 7: Canonical and biological pathways found by IPA in
the D1 vs. D9 hatchling contrast. The AR-DEGs identified in the D1 vs.
D9 contrast were assigned by IPA to overrepresented canonical and
functional and pathways. IPA uses Fisher’s Exact Test to determine
probability (P ≤ 0.05) of each AR-DEG belonging to a particular canonical
pathway or biological function. Each worksheet provides a list of ARDEGs assigned to particular canonical pathways or biological functions,
annotated with gene symbol, Entrez name, log2 ratio, cellular compartment,
type and Entrez protein ID. (XLSX 31 kb)
Additional file 8: Pearson’s correlation analysis of gene expression levels
of 15 “candidate” DEGs determined by genome microarray and verified by
qRT-PCR analyses. A Microsoft Excel file containing the average normalized
expression levels (log2 ratios) of 15 candidate DEGs as determined by
genome microarray analysis and verified by qRT-PCR analysis. The Pearson’s
correlation coefficient (r = 0.9287; P ≤ 0.01, 11 degrees of freedom) indicates
a highly significant correlation between gene expression levels obtained
from both microarray and qRT-PCR analyses. (XLSX 16 kb)
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